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Postmenopausal women are at greatest risk among healthy individuals of 
developing osteoporosis and associated fractures. Nondigestible, fermentable dietary 
carbohydrates have been shown to improve calcium absorption in adolescents and bone-
strength parameters in the rat model. Of particular interest is soluble corn fiber (SCF), 
which improved rat bone strength the most in a survey of novel fibers, and improved 
calcium absorption by up to 13% in teen girls. Hypotheses about the mechanism behind 
this effect revolve around the production of short-chain fatty acids (SCFAs) in the large 
intestine during fermentation. The purpose of this work was to determine if SCF would 
also benefit postmenopausal women and to assess the effect on calcium absorption of a 
chronic increase in cecal concentrations of SCFAs in rats.  
To study the effect of SCF, a randomized, double-blind, placebo-controlled 
crossover design was used to assess the effects of daily consumption of 0, 10, and 20 g 
SCF on bone calcium retention in postmenopausal women. SCF was provided as 
PROMITOR® 85 SCF, which provides 85% fiber, and was consumed as a constituent of 
one muffin and one fruit-flavored drink daily for 50 days. To measure net bone calcium 
xiii 
 
loss, participants’ bones were labeled with 41Ca by administration of ≥50 nCi of 41Ca 
intravenously at least 100 d prior to the start of the study. Every 10 days, 24 h urine was 
collected, and 
41
Ca appearance was measured sensitively by Accelerator Mass 
Spectrometry, while total Ca was measured by ICP-MS. Urinary 
41
Ca:Ca from 
nonintervention periods was used to determine an expected rate of bone loss. A decrease 
in urinary 
41
Ca:Ca from the expected amount during intervention periods reflected 
increased bone retention. A dose-response effect was demonstrated, with 10 g/d SCF and 
20 g/d SCF improving bone calcium retention by 4.8% (P = 0.013) and 7% (0.007) 
respectively. Bone formation marker bone-specific alkaline phosphatase (BAP), and bone 
turnover markers osteocalcin (OC) and N-terminal telopeptide (NTx), were measured at 
the ends of the baseline period and each washout and intervention period. Of the 
biomarkers measured, the only statistically significant difference detected was measured 
in BAP, between placebo and 20 g/d SCF (8%, P = 0.035). Daily SCF consumption 
significantly increased bone retention in postmenopausal women. It is estimated that 20 
g/d SCF would improve bone balance by 50 mg/d, or 2.5% total body BMC per year if 
the effect persists. 
To assess the effectiveness of SCFAs to increase calcium absorption, rats were 
chronically dosed in a randomized, placebo-controlled trial with SCFAs. Twice daily, the 
rats received 0, 300, or 600 umol SCFA conjugate base directly to their ceca through a 
cecal catheter. At the end of 11 days, 
45
Ca was administered to their ceca, and 
45
Ca 
appearance was measured in their plasma. No statistically significant difference was 
observed between treatments. 
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These studies indicate that SCF, in achievable dietary intakes, is effective in 
supporting bone health in postmenopausal women, but also that increasing SCFA 
concentration in the large intestine may not be the only mechanism causing this benefit. It 
is possible that the protocol used to assess the effect of chronic SCFA dosing on calcium 
absorption is inadequate. New protocols should be considered, and other mechanisms, 








Osteoporosis is a worldwide problem, resulting in millions of fractures annually 
(1). Primarily a disease of age, it afflicts an estimated one-in-two women and one-in-five 
men over the age of 50 (2).  Osteoporosis is characterized by low bone-mass, with an 
exaggerated loss of trabecular bone and structure. The result of this condition is weak, 
brittle bones that may break due to minor falls or impacts. 
The costs of osteoporosis are great. It is estimated that, in the U.S. alone, the 
annual fiscal burden of osteoporosis is $19 billion annually, relating to two million 
fractures (2). This is only expected to grow in the coming years. Projections estimate that 
by 2025, the annual cost will increase to $25.3 billion, related to three million fractures. 
In addition to the monetary expense and physical pain of fracture, one in five people 
suffering a hip fracture will die within one year of the event. Many of those who survive 
are unable to independently complete simple physical tasks, such as walking a block or 
climbing stairs, 2 years after the fracture (3). 
Calcium accounts for 31% of bone mass, and is critical for maintaining bone 
strength. While 99% of total body calcium is stored in bone, its concentration in blood is 
tightly regulated. When total absorbed calcium is too low to make up for obligatory 
losses, bone resorption is triggered to maintain homeostasis (4).  Chronic bone resorption, 
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paired with inadequate bone deposition, can lead to osteoporosis. Thus chronic 
inadequate dietary calcium can lead to osteoporosis.  
Individuals in all age groups, except for young men, are at substantial risk of 
inadequate dietary calcium (5). Unfortunately, recent changes in dietary patterns and 
concern over the safety of calcium supplements are likely increasing the risk of calcium 
inadequacy. Milk consumption, the source of most dietary calcium in the U.S., is 
declining (6). Likewise, calcium supplement use in the U.S. was down to 18% in 2013 
from 22% in 2011 (7). The decline in consumption of relatively bioavailable dietary 
calcium presents a challenge for professionals striving to reduce incidence of 
osteoporosis.  One dietary strategy is to improve calcium absorption efficiency.  
The effect of dietary calcium absorption enhancers, including non-digestible, 
fermentable carbohydrates has been studied (8). These carbohydrates remain unaffected 
by human digestion, reaching the large intestine intact. There they are fermented by 
bacteria into short-chain fatty acids (SCFAs) and other metabolites. The primary 
hypothesis is that through the production of SCFAs, colonic pH is reduced, increasing 
calcium solubility and ionization, and ultimately allowing for greater paracellular 
diffusion. Randomized controlled trials (RCTs) with rats (9-18), adolescents (19-24), and 
postmenopausal women(25-27) have generally, but not always (20, 28, 29), shown that 
calcium absorption is improved with dietary supplementation of non-digestible, 
fermentable carbohydrates. 
Of particular interest is soluble corn fiber (SCF), a novel fiber recognized for its 
tolerability (22, 30), and bone-strengthening effects in the rat model (31). Two studies 
were recently carried out in adolescents showing 12-13% improved calcium absorption 
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with 10 – 20 g/d SCF (22, 32). However, no studies have been carried out assessing the 
bone-protective effects of SCF in postmenopausal women, the population most affected 
by osteoporosis due to hormone changes, in addition to low calcium status. The purpose 
of this work was to explore both the benefit of SCF on bone in postmenopausal women, 
and the mechanism by which this effect occurs.  
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Widely known as the primary mineral constituent of bone, calcium likely 
encourages other health-promoting effects such as reduced risk for high blood pressure, 
colon cancer, and cardiovascular disease (1). However, in an evaluation of adults and 
adolescents in 20 countries, individuals in all groups, except for young men, had a 
substantial risk of inadequate calcium intake (2). Furthermore, calcium absorption by 
post-menopausal women, a segment of the population with great risk for low calcium 
status, is only approximately 30% or less from one serving of dairy or 300g supplements. 
One strategy to enhance calcium status is to increase the absorption efficiency of this 
mineral.  
Historically, calcium absorption enhancement strategies have primarily focused 
on identifying the most soluble form of calcium (3). Recently, efforts in several fields, 
including nutrition, have begun to focus on leveraging microbial cell populations in and 
on the human body. Such cells account for an estimated 95% of all the cells in the body 
(4), and some postulate that over the course of millennia, humans have evolved to rely on 
microbial colonies as a kind of symbiote-dependent super organism. Indeed, human 
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health parameters modulated by microbes include brain function, cancer development, 
and nutrient absorption (5). Due to their ability to modulate health through gut bacteria, 
prebiotics, which are thought to aid the absorption of certain minerals, have become the 
focus of much calcium-related research. 
2.1  What Are Prebiotics? 
Prebiotics are dietary components, primarily carbohydrates, that are selectively 
fermented by beneficial microbes in the large intestine, resulting in positive health 
outcomes for the human host. These compounds come from a variety of sources, 
including plants, animals, and synthetic production.  
Disaccharides, oligosaccharides, and polysaccharides, carbohydrate members of 
the prebiotic family vary in both chain length and bond character. Where digestible 
saccharides primarily contain α(1→4), α(1→6) bonds, and the occasional β(1→4) bond 
(in the case of lactose) between sugar molecules, prebiotics additionally contain an array 
of α(1→2), β(1→2), β(1→3), β(1→6), and other bonds that are resistant to human 
enzymes. It is possible that variation in chain length and bond type could be responsible 
for differences in prebiotic effectiveness. 
The health gains of prebiotics are primarily a result of their consumption and 
fermentation by beneficial gut microbiota, which result in two distinct benefits: the 
feeding of good intestinal bacteria and the release of short-chain fatty acids. First, by 
providing targeted nutrition to good bacteria, such as bifidobacteria, prebiotics encourage 
these colonies to grow and become metabolically active, providing the human host 
several favorable outcomes. These include crowding out pathogenic species, relieving 
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symptoms of lactose intolerance, producing B-vitamins, controlling blood cholesterol 
levels, relieving gastrointestinal distress, and modulating nutrient absorption (4).  
The second distinct benefit is the production and release of short-chain fatty acids 
(SCFAs) through fermentation. Short-chain fatty acids include acetate, butyrate, and 
propionate, and are associated with several health gains (6). As the preferred energy 
source of colonic mucosal cells, butyrate is important to colon health and function. When 
SCFAs are eaten as part of the diet the majority are absorbed by the small intestine; 
prebiotics, however, are not broken down in the small intestine, but are instead fermented 
into SCFAs in the colon. Eating foods that are subsequently fermented into SCFAs is one 
of the only ways to consistently provide these important nutrients to the large intestine. 
Thus, prebiotics not only serve as nutrients for gut microbiota, but also for the large 
intestine itself. 
2.2 Calcium Absorption 
The body absorbs calcium both actively and passively, potentially at multiple 
points through the digestive tract. Passive absorption occurs through paracellular 
diffusion along the length of the intestine. Active absorption occurs through calcium 
transporters primarily in the small intestine, though recent evidence suggests that the 
large intestine houses active transport also. Zhao et al. (7) showed through kinetic 
modeling that when rats are fed a small bolus dose of calcium, the calcium is absorbed 
monophasically. However, when rats are fed a large bolus dose of calcium they absorb it 
biphasically. This suggests two relatively efficient sites of calcium absorption, the first, 
and potentially the second, being saturable. The timing and biphasic nature of calcium 
13 
 
absorption when the dose is high is consistent with absorption in the small and large 
intestines. This suggests that either passive diffusion is more effective in the large 
intestine than in the small intestine, or that the large intestine is also capable of active 
calcium transport. 
2.3 Prebiotic Mediated Calcium Absorption 
Prebiotics have been linked with increased calcium absorption in the large 
intestine. For example, ovariectomized (OVX) rats have diminished calcium absorption 
and are used to model the postmenopausal condition. Mitamura et al. (8) found that a 
raffinose intervention restored calcium absorption in OVX rats. This benefit was not seen 
in rats that were cecocolonectomized, suggesting that extracting the cecum and colon 
removed the site of calcium absorption. Furthermore, prebiotics remain essentially 
unaffected throughout digestion until they arrive in the large intestine. The exact process 
by which prebiotics enhance calcium absorption is unclear. However, potential 
mechanisms that prebiotics may work through include changing the luminal environment 
of the large intestine, modifying the composition of the large intestine, or by mediating 
gut microbial population of the large intestine.  
2.3.1 Changes in the Lumen Environment 
One popular hypothesis is that the short-chain fatty acids generated from 
carbohydrate fermentation are the driving force behind increased calcium absorption.  
The theory is that as SCFA concentration increases, the luminal pH of the colon 
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decreases. This causes greater ionization and solubility of dietary calcium, leading to 
greater active transport and passive diffusion across the membrane of the large intestine.  
While the argument is compelling, a good amount of evidence suggests that 
decreased luminal pH is not the only player, or even a dominant player, in prebiotic-
mediated enhanced calcium absorption. Mineo et al. (9), using the Ussing chamber 
method to examine rat colon segments, found that treating the cells with SCFAs 
increased calcium absorption (Figures 4.1 and 4.2), while treating them with HCl did not, 
indicating that solely decreasing luminal pH does not drive calcium absorption in the 
large intestine. 
Interestingly, Yonezawa et al. (10) found that treating cells from the breast cancer 
cell line MCF-7 with SCFAs butyrate, propionate, or acetate increased cellular 
concentrations of calcium. When G-protein GPR43 was silenced, the effect observed due 
to propionate was inhibited. Thus, it was hypothesized that SCFAs had a signaling effect 





Figure 2.1 SCFAs Increase Calcium Absorption in the Intesine Ex Vivo 
 
 
Figure 2.2 Individual SCFAs Increase Cecal Calcium Absorption Ex Vivo in a Dose-
Dependent Manner 
 
Short-chain fatty acids increase calcium absorption in rat cecal and colon segments ex 
vivo. In this experiment 130 mM SCFA mixture was added to the mucosal side of cecal and colon 
segments engaged in a using chamber. Calcium concentration was measured on the serosal side of 
the segments every 15 minutes. Segments treated with SCFA were more efficient at absorbing 
calcium over time than segments not treated with SCFA (p<0.001). Reprinted from Life Sciences, 
Volume 69, Mineo et al., Short-chain fatty acids enhance diffusional Ca transport in the 
epithelium of the rat cecum and colon, p 521, 2002, with permission from Elsevier. 
Various SCFAs increase calcium absorption in cecal segments ex vivo in a concentration-
dependent manner. These values were measured 30 minutes after incubation. Values not 
sharing a common letter are significantly different (p < 0.05). Reprinted from Life Sciences, 
Volume 69, Mineo et al., Short-chain fatty acids enhance diffusional Ca transport in the 
epithelium of the rat cecum and colon, p 521, 2002, with permission from Elsevier. 
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Other mechanisms may play a role. For example, in a randomized trial examining 
the effect of several prebiotic fibers on calcium absorption in rats, Weaver et al. (11) 
showed that cecal content weight was much more correlated with enhanced calcium 
absorption than cecal SCFA concentration. Differences in cecal content weight between 
interventions are likely a function of the water-holding capacity of individual prebiotics. 
It has been proposed that prebiotics leading to increased cecal content weight may 
improve calcium absorption due to increased molecular mobility and greater mineral 
solubilization. Other postulated mechanisms involve changes to the large intestine. 
2.3.2 Changes to the Large Intestine 
Some investigators have proposed that prebiotics enhance calcium absorption by 
changing the large intestine itself. Fukushima et al. (12) found that caco-2 cells treated 
with SCFAs developed significantly more calbindin-D9k, a vitamin-D mediated calcium 
transporter, than untreated cells. Interestingly, neither vitamin D receptor, nor the cell 
proliferation marker CDX2 increased in caco-2 cells treated with SCFAs. Similarly, 
Nzeusseu et al. (13) showed that in rats, inulin and oligofructose consumption increased 
the expression of calbindin-D9k, though the effect seen by inulin was much stronger. 
Prebiotics may also increase calcium absorption by increasing colon cell count 
and surface area. Nzeusseu et al. (13) saw an increase in cecal wall weight in rats fed 
inulin or oligofructose. Perez-Conesa et al. (14) observed a similar effect when they 
provided an intervention to four-week-old Sprague-Dawley rats consisting of diets 
containing 1.2%, 5%, and 10% GOS for 30 days. At the end of the trial, they analyzed 
cecal and colon cell density and crypt depth, as well as femur and tibia mineral contents. 
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They found that under all interventions, the proximal colon experienced a significant 
increase in crypt depth and cell density compared to the control. Similarly, in the distal 
colon all prebiotic interventions significantly increased crypt depth, while cell density 
was only significantly increased in rats consuming 1.2% and 5% diets. As expected, all 
GOS interventions significantly increased calcium content in both the femur and tibia 
compared to control groups, implying a connection between increased colon cell count 
and surface area, and calcium uptake. Interestingly, researchers saw similar results when 
feeding the rats with probiotics—live exogenous beneficial microbes.  Perhaps calcium 
absorption is increased when prebiotics are consumed because of changes in gut 
microbial populations, rather than changes to the human cells of the large intestine. 
2.3.3 Changes to the Gut Microbial Population 
Changing gut microbial populations may also affect calcium absorption. These 
changes may occur through consuming prebiotics or probiotics. Few studies have been 
performed to determine the effect of consuming probiotics, live exogenous beneficial 
microbes, on mineral absorption. Narva et al. (15) showed that post-menopausal women 
who consumed milk fermented by Lactobacillus helveticus had increased calcium 
absorption above those who consumed milk fermented by other lactic acid bacteria.  
Kruger et al. (16) showed that true calcium absorption in male rats consuming feed 
containing Lactobacillus rhamnosus for 3 weeks was significantly increased over those 
consuming a control diet. These rats also experienced a positive, non-significant increase 
in fractional calcium retention. Importantly, in this study, the intervention group did 
consume more total calcium than the control group. Kruger et al. (16) also showed that 
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the bones of OVX rats that consumed Lactobacillus rhamnosus were more like the bones 
of sham-operated rats than the bones of other OVX rats that did not consume the 
probiotic. Perez-Conesa et al. (17) showed that consuming the probiotics Bifidobacterium 
bifidum and Bifidobacterium longum either alone, or in conjunction with prebiotics, 
increased apparent calcium absorption. In this study, the increase in calcium absorption 
was also correlated with an increase in crypt depth and cell density in the proximal and 
distal colon. It is unclear how probiotics increase calcium absorption, but it may occur 
due to a change in luminal environment, large intestine structure, or through some other 
metabolic activity unaccounted for by specific bacterial species. 
Like probiotics, prebiotics can change the makeup of gut microbial populations. 
Weaver et al. (18) showed that intestinal microbial populations in rats fed 2%, 4%, 6%, 
or 8% GOS diets were similar within a dose of GOS, but different between GOS levels. 
Similarly, Clavijo-Gutierrez et al. (19) found that gut microbial populations of adolescent 
girls became similar when they moved from a self-selected diet to a controlled diet. 
When soluble corn fiber (SCF), a prebiotic, was added to the controlled diet, another 
microbial population shift occurred. Gut microbiota between individuals on the SCF-
containing diet were similar; however, gut microbiota between individuals on SCF-
containing and non-SCF diets varied. Dietary changes may transform the composition of 
gut microbial populations by giving an advantage to those organisms that can best utilize 





2.4 Types of Prebiotics 
2.4.1 Disaccharides 
As one category of the prebiotic family, disaccharides are carbohydrates 
consisting of two sugar units. Of these prebiotics, perhaps the most studied is lactulose 
(4-O-β-d-galactopyranosyl-d-fructose). This man-made prebiotic is created during heat-
sterilization of milk, and was one of the first non-digestible carbohydrates to be linked 
with enhancing gut microbial populations (20).  
Seki et al. (20) investigated the effects of 2g lactulose/day and  4g lactulose/day 
on 24 young adult men in a  double-blind, placebo-controlled, dual-stable isotope study. 
They found that subjects who consumed 4g lactulose in a test meal experienced 
significantly higher calcium absorption and urinary excretion than the control group. 
They did not, however, experience a change in bone resorption markers. It is unclear if 
calcium balance improved, or if the additionally absorbed calcium was merely excreted. 
2.4.2 Oligosaccharides 
While experts sometimes disagree on the exact number of polymerized sugar 
units required to make an oligosaccharide, definitions usually range from 3 to 10 sugar 
units. Many oligosaccharides exist, but the most common classes of prebiotic 
oligosaccharides are fructooligosaccharides and galactooligosaccharides. 
Fructooligosaccharides (FOS) include a variety of compounds of varying in chain 
length, primarily composed of fructose molecules connected by β(1→2) linkages and 
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capped with a terminal glucose. While some FOS are synthetically made, many are found 
in such plants as bananas, Jerusalem artichoke, chicory, asparagus, and onions.  
Fructooligosaccharides (Figure 4.3) have frequently been tied to enhanced 
calcium absorption. For instance, Morohashi et al. (21) conducted a 3-day metabolic 
study on rats that revealed that calcium absorption, excretion, and balance were all 
increased when the rats were fed a diet with 5% FOS. Similarly, van den Heuvel et al. 
(22) found that adolescent males who consumed 15g FOS/day for 9 days experienced 
significantly higher fractional calcium absorption. However, Martin et al. (2010) saw no 
effect on adolescent girls who consumed 9g per day of a FOS/Inulin blend for 3 weeks. 
Another common prebiotic type, galactooligosaccharides (GOS) are found as a 
mixture of oligosaccharides of varying length. Similar to FOS, GOS is comprised of 
galactose units bound by various β(1→2), β(1→3), β(1→4), and β(1→6) linkages with a 
terminal glucose (Figure 4.3). Galactooligosaccharides are found naturally in milk and 
can be created synthetically by the enzymatic action of glycosidic hydrolases on lactose.  
Like fructoligosaccharides, galactooligosaccharides (GOS) have been shown to 
increase calcium absorption. van den Heuvel et al. (23) saw that postmenopausal women 
who consumed 20g GOS per day experienced increased calcium absorption. The 
intervention did not affect calcium excretion. Because the storage site for calcium is 
bone, it is inferred that this excess calcium was being used to create new bone. In another 
study, dos Santos et al. (24) showed that both gastrectomized and sham-operated rats 
experienced increased calcium absorption when they were fed 5% GOS diets. Similarly, 
Weaver et al. (18) showed that rats consuming diets enriched with 2%, 4%, 6%, and 8% 
GOS had a net increase in calcium balance in a dose-dependent manner. Whisner et al. 
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(25) also documented a positive effect from GOS intervention. In this study, adolescent 
girls were fed 0g GOS, 2.5g GOS and 5g GOS twice daily for 3 weeks. Both 
interventions, low and high dose, were shown to significantly increase calcium 
absorption, though the benefit was not dose-dependent. 
 
Figure 2.3 General Chemical Structures of GOS and FOS. 
 
2.4.3 Polysaccharides 
Polysaccharides are composed of many sugar subunits and include cellulose, 
hemicellulose, gums, polyglycans, and polyfructans. Some, like cellulose and 
hemicellulose, are not well fermented and thus cannot be prebiotics. Gums, polyglycans, 
and polyfructans, on the otherhand, are well fermented which may mean they have 
prebiotic potential. Thus, calcium absorption research on these compounds may be 
warranted. For example, Kawase et al. (26) showed that, under ex vivo conditions, 
intestinal segments from rats fed a diet with 7.5% gum arabic for 10 days had more 
efficient calcium absorption than intestinal segments from control rats. The most 
common polyfructan used as a prebiotic is inulin, the parent compound to FOS. Coudray 
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et al. (27) found that rats on a diet supplemented with 10% inulin had increased calcium 
absorption over animals on non-supplemented diets.  
2.4.4 Synbiotics 
Occasionally, prebiotics are eaten in tandem with probiotics, an external source of 
beneficial bacteria. When these two products, prebiotics and probiotics, are consumed at 
the same time it is deemed a synbiotic. Examples of synbiotics products include yogurt 
and kefir. Synbiotics, like prebiotics and probiotics, have been shown to increase calcium 
absorption.  For instance, Perez-Conesa et al. (17) fed weanling rats a diet containing 
probiotics but no GOS, as well as diets containing 1.2%, 5%, or 10% GOS with and 
without probiotics. At the end of the study, all interventions showed significantly higher 
apparent calcium retention than the control group. The synbiotic group did not appear to 
confer greater benefit to calcium retention than just prebiotics or probiotics alone.  
2.4.5 Mixed Prebiotics 
It has been hypothesized that the various types of prebiotics are effective at 
different locations in the large intestine. Some prebiotics are small and ferment quickly. 
Others take longer to ferment because they are long, highly branched, and include many 
kinds of bonds. It is possible that rapidly fermenting prebiotics may primarily affect the 
proximal large intestine, while slowly fermenting prebiotics may primarily affect the 
transverse and distal colon. However, it is still unknown if the fermentation profile of 
prebiotics is an important factor in their mineral-absorption enhancing qualities. 
Therefore, some researchers have studied combinations of prebiotics to gain insight about 
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fermentation profile and its effect on maximization of calcium absorption. Holloway et 
al. (28) performed a randomized, double-blind, crossover study using a FOS/Inulin 
mixture intervention with postmenopausal women. Participants undergoing the 
intervention consumed 10g of the prebiotic mixture each day for 6 weeks. The study 
showed a significant increase in calcium absorption after the intervention. This effect was 
primarily seen in subjects who had low lower-spine bone mineral density.   
In a balanced, randomized, crossover design, Griffin et al. (29) fed girls either 8g 
FOS/day or 8g FOS+inulin mixture/day for 3 weeks. In the mixed prebiotic intervention, 
calcium absorption was significantly higher than placebo, whereas the intervention with 
only 8g FOS did not increase calcium absorption. Importantly, there was no inulin-only 
intervention, and so it is not possible to separate an effect from inulin itself compared to 
the mixed prebiotic. 
Interestingly, Hicks et al. (30) found no difference in absorption between infants 
consuming formula enriched a with 4g/L GOS+Polydextrin mixture and those consuming 
non-enriched forumla. Abrams et al. (31) showed that adolescents who received an 8g/d 
dose of short- and long-chain inulin type fructans experienced an 8% increase in calcium 
absorption after 8 weeks, and a 6% increase in calcium absorption after 1 year, over the 
control group. 
2.5 Factors that Influence Prebiotic Mediated Calcium Absorption 
As described above many, but not all, studies suggest prebiotics can have a 
promoting effect on calcium absorption. The following sections review distinct factors 
that may influence the efficacy of prebiotics on calcium absorption. 
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2.5.1 Prebiotics and Age 
One of the many variables that may impact calcium absorption mediated by 
prebiotics is age. Young people are generally more active than older individuals, inducing 
more load bearing events on their skeletons, which encourages bone growth. Hormone 
levels between older and younger individuals also differs drastically. The most critical 
age stages for bone health are post-menopause, when changes in hormone levels leads to 
increased bone loss, and adolescence, when the majority of bone is accrued. 
Several studies indicate that loss of calcium absorption due to the post-
menopausal condition could be alleviated by prebiotics. In one crossover study (23), a 
daily dose of 20g GOS for 9 days increased true calcium absorption in post-menopausal 
women compared to a placebo. Similarly, another study (28) showed that fractional 
calcium absorption in post-menopausal women increased significantly when they 
consumed 5g FOS/day for 6 weeks. Interestingly, one study (32) showed no effect of 10g 
FOS/day for 5 weeks on women 2-6 years post menopause. However, they did see a 
positive trend in women 6 or more years post menopause. Unfortunately, only six 
participants fell into this age range. In OVX rats, a model intended to mimic the post-
menopausal condition, loss of calcium absorption was restored when the rats were fed a 
diet with 3% raffinose (8). 
Data for adolescents are less consistent. Perhaps the best example, one study (29) 
showed that girls who consumed 8g FOS+inulin mixture/day for 3 weeks experienced 
significantly higher calcium absorption. Yet a different study (33) showed that adolescent 
girls who consumed 9g of the same FOS+inulin mixture/day for 3 weeks did not have 
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increased calcium absorption. The primary difference between these two studies was that 
the effective intervention was provided with orange juice, while the ineffective 
intervention was provided in ready-to-eat cereal. Additionally, subjects in the study 
where no difference was found had high fractional calcium absorption before the study 
began. Prebiotic supplementation may not have been able to increase it further. 
In agreement with these studies, Coudray et al. (34) showed that aged rats, 
animals suffering from diminished calcium absorption, experienced a greater increase in 
calcium absorption from inulin intervention than young rats did. However, this study 
used male rats, and was not comparing OVX rats to young female rats. 
2.5.2 Intervention Length and Calcium Status 
Both intervention length and calcium status of subjects are thought to be 
important factors in how well prebiotics enhance calcium absorption. In one study (27), 
rats were fed a 10% inulin diet for 13 days. Animals on either low- or high-calcium diets 
experienced increased calcium absorption over animals on normal calcium diets. When 
the trial was extended to 37 days, the animals on the low calcium diet retained the 
enhanced calcium absorption, while the animals on a high calcium diet did not. This may 
be because vitamin D mediated calcium absorption is downregulated when calcium 
absorption is high. Therefore, because the inulin enhanced calcium absorption, active 
calcium absorption may have been hormonally downregulated over time in the rats on 
high-calcium diets, leading to the loss of the benefit seen in the short-term. Supporting 
this theory, several long-term studies using subjects with adequate calcium intake have 
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shown significant increases in calcium absorption when they were fed prebiotics (18, 24, 
28, 31).  
2.5.3 Dose Amount 
Intervention dose amount likely determines the strength of the prebiotic response. 
In one study (17), rat weanlings that consumed a 10% GOS diet absorbed more calcium 
than those on 1.2% or 5% GOS diets. Similarly, a separate study showed that growing 
rats consuming 2%, 4%, 6%, and 8% GOS diets experienced increased calcium 
absorption in a dose-dependent manner. However, Whisner et al. (25) showed that 
adolescent girls with adequate calcium absorption had increased calcium absorption when 
consuming either 2.5g or 5g GOS/day. Curiously, in this case, 2.5g GOS/day was more 
effective than 5g GOS/day. 
2.5.4 Genetics and Pre-Existing Conditions 
Subject genetics may play a role in the effectiveness of prebiotic intervention. 
Many studies have been performed in rat populations, which while practical are not the 
ideal representation of human physiology. For instance, the cecum plays a much more 
substantial role in fermentation in rats than in humans. Additionally, variation across 
individuals in a species can greatly change calcium absorption. Replogle et al. (35) 
showed that, in rats, hormonal response to calcium status varied significantly based on 
the rat phenotype. Weaver et al. (36) has observed similar effects in human populations 
with different genetic histories. A similar effect could be seen with prebiotic 
interventions. In fact, some studies have used the terms responders and non-responders 
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to differentiate individuals with different sensitivity to prebiotics. One study showed that 
postmenopausal women with lower lumbar BMD were more likely to respond to 
prebiotic intervention (28). Another (32) found that women more than 6 years post 
menopause were more likely to respond than those closer to menopause. 
2.6 Prebiotics on Bone 
While increasing calcium absorption is a first step towards improved health 
outcomes, the primary end outcome of concern is bone strength. This is usually 
quantified by a proxy measure, such as bone mineral density, or trabecular and cortical 
thickness. There is evidence that suggests consuming prebiotics improves these 
parameters. Abrams et al. (31) showed that after 1 year of consuming a FOS+inulin 
mixture, adolescents had significantly greater whole-body bone mineral content and bone 
mineral density than the control group. Similarly, Roberfroid et al. (37) found that a diet 
consisting of 0.5 and 1.0% inulin increased whole-body bone mineral density and whole-
body bone mineral content in rats. Another study (13) showed that, in rats, a 5% GOS 
intervention for 3 months significantly increased trabecular bone area over control. 
Additionally, a 5% inulin intervention for 3 months increased trabecular bone area more 
than the GOS intervention. It also increased trabecular bone area in the lower lumbar 
area, which the GOS intervention did not. 
The ultimate test of bone quality is bone strength. Weaver et al. (18) showed that 
young growing rats had greater volumetric bone mineral density and peak breaking 
strength when fed a diet with 2%, 4%, 6%, and 8% GOS for 8 weeks. The same research 
group (11) compared the effect of eight different prebiotic fibers on rat calcium 
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absorption, bone quality measurements, and peak breaking force. These fibers included 
two resistant starches, soluble corn fiber (SCF), soluble fiber dextrin (SFD), pullulan, 
polydextrose, inulin, and a FOS+inulin mixture. Except SCF and pullulan, the prebiotics 
were effective at increasing calcium content of the rats’ bones. While the only fiber to 
significantly increase femur uptake of calcium was the FOS+inulin mixture, only SFD 
and SCF significantly increased femoral peak breaking strength. The parameters that both 
SCF and SFD significantly increased, and the inulin/FOS mixture did not, were total 
femoral BMD and cortical thickness.  These data indicate that some prebiotics are more 
effective at enhancing bone formation, even when others may increase calcium uptake 
more efficiently. Scholz-Ahrens et al. (38) found that in OVX rats, tibial bone was spared 
with an intervention of high calcium, FOS, or a combination of the two. Interestingly, the 
spared bone had a different trabecular architecture depending on whether the intervention 
included high calcium, FOS, or both. This indicates that some of the benefit of prebiotics 








Figure 2.5: SCF and SFD Improve Bone Strength in Rats. 
 
 
Prebiotics help maintain bone quality. Image (A) is a representative contact 
microradiograph of the proximal tibia in control ovariectomized rats. Image (B) is a 
representative contact radiograph of the proximal tibia in ovariectomized rats that were fed a 
5% FOS/Inulin mixture. These images show that prebiotic intervention prevented both cortical 
and trabecular bone loss. Scholz-Ahrens et al., Effect of oligofructose or dietary calcium on 
repeated calcium and phosporus balances, bone mineralization and trabecular structure in 
ovariectomized rats. British Journal of Nutrition, 2002, Oct 8(4):368, reproduced with 
permission. 
Soluble corn fiber (SCF; slashed bars) and soluble fiber dextrin (SFD; open bars) fed 
rats had improved femoral bone quality over control fed rats. Reprinted with Permission from 
Weaver et al. Novel Fibers Increase Bone Calcium Content and Strength beyond Efficiency of 
Large Intestine Fermentation. J Agr Food Chem. 2010 Aug 25;58(16):8952-7. 
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2.7 Conclusion and Future Work 
The gastrointestinal tract hosts many trillions of microbes, and through prebiotics 
humans might be able to unlock some of their health-promoting potential. The majority 
of reports evaluating the effect of prebiotics on calcium absorption indicate that various 
types of prebiotics enhance calcium absorption and bone deposition. Further research is 
necessary to determine how calcium absorption is enhanced, and whether bone strength is 
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3.  SOLUBLE CORN FIBER INCREASES CALCIUM RETENTION IN 





Soluble corn fiber (SCF) significantly improves calcium absorption in adolescents 
and bone strength and architecture in rodent models. In this study, we aimed to see if 
PROMITOR® SCF 85, which provides 85% dietary fiber, would also benefit 
postmenopausal women. We used our novel technology of determining bone calcium 
retention—by following urinary appearance of 41Ca from prelabeled bone—to rapidly 
and sensitively evaluate the effectiveness of SCF to reduce bone loss. A randomized-
order, crossover, double-blinded trial was performed in 14 healthy postmenopausal 
women to compare 0 g/d, 10 g/d, and 20 g/d fiber from SCF for 50 days. A dose-response 
effect was demonstrated with 10 g/d SCF and 20 g/d SCF improving bone retention by 
4.8% (P = 0.013) and 7% (P = 0.007) respectively. Bone turnover biomarkers N-terminal 
telopeptide and osteocalcin were not influenced by the interventions; however, a 
significant increase in the bone-formation marker bone-specific alkaline phosphatase was 
detected between 0 g/d SCF and 20 g/d SCF levels (8%, P = 0.035). Daily 
PROMITOR®SCF consumption significantly increased bone calcium retention in 





Osteoporosis is an age-related condition resulting in demineralization of the 
skeleton which is influenced by genetics as well as various environmental factors. Diet 
and nutrition, including calcium intake and absorption, are critical for maintaining bone 
mass and strength at all stages of life, thus reducing the risk for osteoporosis later in life. 
When women experience menopause and estrogen production ceases, bone resorption far 
exceeds mineralization, resulting in potential loss of bone mass and strength and 
increased risk of bone fracture. Additionally, postmenopausal women are at substantial 
risk of inadequate calcium intake (1). Yet due to recent concern over a link between 
calcium supplementation and risk of cardiovascular disease and myocardial infarction 
(2), calcium supplement use has dramatically declined. Therefore, it is particularly 
important at this stage of life to incorporate alternative dietary routines that will 
maximize bone health.  
Previous studies in our lab have shown that fermentable carbohydrates, 
specifically soluble corn fiber (SCF), increase calcium absorption in adolescent boys and 
girls, and improve bone properties in a rodent model. Bone mineral content, bone mineral 
density, and peak breaking force of the femur were all increased in 4-week-old male rats 
(3). In teen boys and girls, consuming a chronic dose of 12 g/d SCF over a 3-week period 
as part of a controlled diet resulted in a 12% increase in calcium absorption compared to 
a placebo (4). Another study, with teen girls only, showed that interventions of either 10 
g/d or 20 g/d SCF over a 4-week period increased calcium absorption by 13% compared 
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to a placebo (5). However, the effect of SCF on bone health in postmenopausal women 
has not been explored.  
One randomized, double-blinded, crossover study (6) used a single oral calcium 
isotope (
44
Ca) to assess the effect of 10 g/d short-chain fructoologisaccharides, a 
fermentable carbohydrate, on calcium absorption in postmenopausal women. While no 
effect was detected overall, there was a trend (P < 0.1) for increased calcium absorption 
in women >6 y postmenopausal, despite the small subsample size (6 individuals) and the 
relatively imprecise method used. Further investigation on bone-protective qualities of 
fermentable carbohydrates with a larger sample and a very precise method is warranted. 
Our laboratory has developed a method to screen efficacy of interventions to 
improve bone calcium retention using 
41
Ca, a long-lived radio isotope (t1/2 = ~10
5
 y), to 
label the skeleton (7). Due to the great measurement sensitivity of accelerator mass 
spectrometry (AMS), urinary 
41
Ca can be followed in an individual for their lifetime after 
only a single dose. Changes in urinary 
41
Ca can be used to estimate the effects of diet or 
other interventions on bone calcium retention rapidly and sensitively. This study was 
designed to measure the dose-response effect of chronic SCF intake over a 50-day period 
on bone resorption in healthy postmenopausal women using the 
41
Ca methodology.  
3.3 Subjects and Methods 
3.3.1 Subjects 
Fourteen healthy postmenopausal women were enrolled in the study. Each signed 
a written consent form and completed a screening questionnaire, which included a brief 
medical history, diet assessment, physical-activity evaluation, and 4-day diet record. All 
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participants were >6 years post-menopausal due to natural menopause or total 
hysterectomy and had a blood sample screened for general blood chemistries, verifying 
normal physiological function. Exclusion criteria included taking medication known to 
affect calcium metabolism, using illegal drugs, having kidney disease or other diseases 
known to affect calcium metabolism, or having broken a bone within six months prior to 
the start date of the study. Participants discontinued vitamin and mineral 
supplementation, except for a multivitamin (Spectravite® Advanced Formula) provided 
by the researchers for daily consumption. This multivitamin provided 200 mg/d calcium 
and 400 IU/d vitamin D. 
3.3.2 Study Design 
This study was a randomized, placebo-controlled, double-blind crossover trial 
with three intervention periods beginning after a 100-day equilibration period and a 50-
day baseline period. The equilibration period was initiated for individual subjects with 
the IV administration of 50 nCi 
41
Ca, a long-lived radio isotope. This isotope was allowed 
to deposit into bone and to equilibrate with whole-body calcium for at least 100 days. 
During this equilibration period, subjects collected 24-h urine monthly to monitor the 
decrease in 
41
Ca urinary excretion. Two of the subjects were dosed with 
41
Ca for a 
previous study and bypassed the equilibration phase. Due to the long half-life of this 
isotope, urinary 
41
Ca values were easily measureable in these participants.  
Subsequent to the equilibration phase, the baseline level of urinary 
41
Ca was 
evaluated over a 50-day baseline period with 24-h urine collections every 10 days. After 
the baseline phase, participants were randomized to receive each of the three doses of 
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soluble corn fiber (0, 10, 20 g/d) in one of six sequences. During intervention phases, 
participants consumed two products daily, including one fruit-flavored drink and one 
muffin, each containing half of the daily SCF dose. The muffins and drinks containing 
SCF (Promitor® Soluble Corn Fiber 85) were provided by Tate & Lyle. 
3.3.3 Anthropometric Parameters and Bone Measurements 
Anthropometric parameters were measured throughout the study. During the 
baseline clinical visit, waist circumference and hip width and depth were measured. Bone 
mineral content and bone mineral density were also measured during that first visit by 
dual-energy X-ray absorptiometry (DXA; GE Lunar iDXA). During morning-time 
follow-up clinical visits at the beginning of intervention and washout phases, standing 
height was measured using a wall-mounted stadiometer (Measurement Concepts; 
QuickMedical®), and fasting weight was measured using a digital scale (Mini Platform 
Stand-on Scale®; Scale-Trionix). 
3.3.4 Measurement of Bone Biomarkers 
 At the beginning and end of the baseline period and the end of each intervention 
and washout phase, fasting blood and urine were collected to measure biochemical 
markers of bone metabolism. The collected biomarkers included bone-specific alkaline 
phosphatase (BAP), osteocalcin (OC), and N-terminal telopeptide (NTx). Serum 
concentration of osteocalcin, a marker of bone turnover, was measured by ELISA (Quidel 
Corporation). The urinary concentration of bone resorption marker NTx was measured by 
ELISA (Alere). Serum concentrations of bone formation marker BAP were determined 
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by ELISA (Quidel Corporation). Creatinine was also measured as a correction value for 
NTx and was measured by an enzymatic colorimetric assay (COBAS Integra, Roche 
Diagnostics Ltd.). Interassay percent coefficient of variation was calculated at 4.8, 9.8, 
and 2.5% for BAP, OC, and NTx, respectively. Intra-assay percent coefficient of 
variation was calculated at 5.1, 7.6, and 8.4% for BAP, OC, and NTx, respectively.  
3.3.5 Compliance and Symptoms 
Intervention compliance was measured through participant self-report and product 
recall. At the end of each intervention period, participants were asked to return any 
remaining intervention muffins and drinks to the researchers. Participants also kept a log 
of when they consumed the products. 
Abnormal gastrointestinal symptoms were monitored every ten days during 
intervention phases. Participants were asked to rate gastrointestinal symptoms on scale of 
0 (no symptoms) to 5 (severe symptoms). The symptoms on the report included 
abdominal pain, bloating, flatulence, diarrhea, and stomach noises. Participants also rated 
their general health. 
3.3.6 Measurement and Statistical Analysis of Bone Calcium Retention 
After bone deposition and equilibration, 
41
Ca is released from and reincorporated 
into bone in proportion to total in-bone and circulating calcium during resorption and 
bone formation, respectively. Thus, changes in urinary 
41
Ca:Ca reflects net bone 
retention. Specifically, a decrease in urinary 
41
Ca:Ca would indicate improved bone 
calcium retention. Urinary 
41
Ca:Ca during all nonintervention (washout and baseline) 
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periods was used to create a projected rate of net bone calcium loss. Urinary 
41
Ca:Ca 
during intervention periods was compared to the projected rate of calcium loss, and the 
difference was averaged per individual and intervention. These average differences were 
used to determine statistics. 
41
Ca was measured by accelerator mass spectrometry (AMS) 
as previously described (8). 
3.3.7 Statistical Analysis of Biochemical Markers and Symptom Severity 
Statistical analyses were performed using SAS (version 9.3, SAS Institute, Cary, 
NC), and statistical significance was set at p ≤ 0.05. The effects of SCF dose on 
biochemical markers of bone turnover were examined using a mixed model general linear 
model. The model included the covariables treatment period and sequence.  Comparisons 
between any dosage level may be modeled, since linear effects are possible.  
To further assess significant differences among biochemical markers, two 
statistical models were constructed using biomarker response variable BAP and an 
explanatory variable, ID. Model 1 (General Linear Model) used an additional explanatory 
variable, DOSE, which represented a linear term in the model. Model 2 (ANOVA Model) 
used an additional explanatory variable, TRT, which represented a categorical term in the 
model. Tukey multiple comparison procedure was also performed.  
Symptom severity between dose levels was compared for each symptom type 




Of the 18 women that were screened, two were withdrawn from the study due to 
medical reasons, and two dropped out for personal reasons. A total of 14 women 
participated in the study. One of those women chose to drop out before entering an 
intervention period for convenience, and another dropped out after two intervention 
periods because of diet changes (Figure 5.1). Compliance and gastrointestinal symptoms 
were calculated based on a sample size of 13 participants, while bone biomarker levels 
and increased bone retention were calculated based on a sample size of 12 participants. 
While there were no exclusion criteria regarding race, all participants were white. 
Participant baseline characteristics are described in Table 5.1. 
Four of the women recruited and two of the women who completed the study had 
undergone hysterectomies, and all were past the stage of rapid menopausal bone loss. 
While these postmenopausal women were comparable to the white female US population 
in regards to BMI, total body BMC, total body BMD, intake of calcium, phosphorus, and 
sodium (9, 10), they had greater femoral neck and lumbar spine BMD (9). They also 
consumed more fiber but tended to consume lower amounts of potassium and magnesium 
(Table 5.2). 
3.4.1 Compliance 
Overall compliance was 92.9 (±1.1%), and there was no significant difference in 
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1 – personal convenience 
Withdrawal 
n 1 
1 – diet changes 
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Table 3.1: Participant Baseline Characteristics  
 Mean ± SD 
Age (y) 59.8 ± 5.0 
Years Postmenopause 12.9 ± 6.8 
Pre-study calcium intake (mg)* 862 ± 371 
BMI (kg/m2) 28.1 ± 5.2 
Total Body BMC (g) 2330 ± 342 
Total Body BMD (g/cm2) 1.11 ± 0.10 
Total Femoral Neck BMD (g/cm2)* 0.89 ± 0.08 
Lumbar Spine BMD (L1-L4) (g/cm2)* 1.12 ± 0.17 
Fat Mass (%) 43.1 ± 7.4 
Lean Mass (%) 53.8 ± 7.1 
(n = 13; * n = 12) 
BMD: Bone Mineral Density.  BMC: Bone Mineral Content. 
 
Table 3.2 Dietary Intake of Postmenopausal Women throughout the Study. 














































250.7 ±  
69.1 
235.4 ±  
97.4 
214.3 ±  
92.4 
199.5 ±  
81.8 
242.5 ±  
75.7 
Total Fiber (g) 
(Excluding SCF) 




14.2 ±  
6.5 
13.7 ±  
6.0 
15.2 ±  
6.8 
Soluble Fiber (g) 
(Excluding SCF) 






4.6 ±  
1.7 
4.7 ±  
1.8 
Total Fiber (g) 
(Including SCF) 




14.2 ±  
6.5 
22.3 ±  
6.9 
31.5 ±  
8.9 
Soluble Fiber (g) 
(Including SCF) 






13.2 ±  
3.3 
21.3 ±  
6.3 
Mean ± SD 
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3.4.2  Gastrointestinal Symptoms 
Severity of gastrointestinal symptoms was low throughout the study. No 
significant difference was observed in the severity of gastrointestinal distress between 
SCF intake levels (0 g/d, 10 g/d, and 20 g/d) (Figure 4.2). 
 
 




3.4.3 Bone Calcium Retention 
Table 5.3 represents the group mean difference between measured and predicted 
urinary 
41
Ca:Ca for each intervention period. Increases in bone calcium retention due to 
SCF intervention were statistically significant in a dose-dependent manner. 
 








































Added Soluble Corn Fiber (g/d) 
* 
** 
SCF consumption improves bone calcium retention compared to predicted values. 
Predicted values, represented as the 0-line, are based on nonintervention periods.  
Only subjects who completed all interventions were included (n =12). 
* p < 0.05; ** p < 0.01. Values are means ±95% CI  
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3.4.4 Bone Biomarkers 
Of the bone biomarkers assessed, neither OC nor NTx, both biomarkers of bone 
resorption, were affected by dietary SCF consumption (OC,p=0.730; NTx, p=0.570). 
However, a statistically significant effect on serum BAP concentration was observed 
between placebo and 20 g/d SCF intervention (p=0.034), though the 10 g/d SCF 
intervention was not significantly different from other levels. 
 
Figure 3.4: Bone Turnover Biomarkers by Intervention 
3.5 Discussion 
We demonstrated in this randomized order, placebo-controlled crossover trial that 
SCF significantly increased bone calcium retention in postmenopausal women in a dose-
dependent manner. Several other studies suggest fermentable carbohydrates could be 
used as a dietary intervention to improve bone health in postmenopausal women. Short-
term dietary intervention of 10 g/d oligofructose-enriched inulin (SYN1) (11), 20 g/d 












Fasting urinary and serum bone biomarkers. n = 12. Mean ± SD.  
*Significantly different from 0 g/d SCF, p < 0.05. 
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increased calcium absorption in postmenopausal women. In contrast, Slevin et al. (14) 
found that 3.6 g/d short-chain fructooligosaccharides (scFOS) did not improve BMD in 
postmenopausal women over a 24-month period, as measured by DXA. Additionally, 
Tahiri et al. (6) found that short-term intervention of 10 g/d scFOS did not improve 
calcium absorption in postmenopausal women. There are several factors that may account 
for the differences observed.  First, the low dose of 3.6 g/d scFOS may not have been 
large enough to create a measurable effect by DXA (14). However, Tahiri et al. (6) used a 
much larger dose and also found a negative effect, suggesting that scFOS may not be as 
effective as other fibers. Second, different fermentable carbohydrates may have distinct 
fermentation rates and patterns (15), which may play a role in their effectiveness in 
enhancing calcium absorption. Third, years since menopause may also play a role in the 
effectiveness of fermentable carbohydrates in influencing bone health. Calcium 
supplementation was more effective at preventing bone loss in hormone-stable 
menopause (> 5y) than in early menopause (16, 17). Additionally, hormone-flux-driven 
bone loss may confound any benefit from fermentable carbohydrates. Further support for 
this comes from the lack of effect with scFOS supplementation in the overall cohort but a 
positive trend detected in women >5 y postmenopausal (n = 6) (6).  
In adolescents, who are experiencing rapid bone calcium accrual, calcium 
absorption has been reported to increase with fermentable carbohydrate supplementation. 
Recently, it was reported that 12 g/d SCF for 3 weeks improved calcium absorption by 
12% in 24 adolescent boys and girls on a low-calcium diet (4). Likewise, 10 g/d and 20 
g/d SCF for 4 weeks improved calcium absorption by 13% in free-living adolescent girls 
(5). Whisner et al. (18) showed in an RCT with 31 healthy adolescent girls that modest 
50 
 
amounts of galactooligosaccharides (5 g/d or 10 g/d) for 3 weeks improved calcium 
absorption by 13%. In a crossover-designed RCT, 15 g/d FOS for 9 days improved 
calcium absorption in adolescent males (19). Griffin et al. (20) showed in an RCT with 
59 adolescent girls consuming 1500 mg/d calcium that 8 g/d FOS for 3 weeks did not 
improve calcium absorption, but a mixture of FOS and long-chain inulin (SYN1) did. 
The beneficial effect of SYN1 was confirmed in a follow-up study of the same design, 
which showed that girls who had low fractional calcium absorption during placebo 
periods were most likely to have improved fractional calcium absorption due to SYN1 
supplementation (21). In contrast, Martin et al (22) found in a similarly designed study 
that 9 g/d SYN1 supplementation did not improve calcium absorption in adolescent girls 
11–13 years old. However, these girls already had high fractional calcium absorption 
levels, which may have reduced the impact of the intervention. A longer RCT assessing 
SYN1 was also performed with adolescent boys (n = 50) and girls (n = 50) (23). After 8 
weeks or 1 year of 8 g/d SYN1, calcium absorption was increased due to SYN1 
supplementation, and after 1 year of supplementation, total body BMC and BMD were 
improved in the intervention group compared to control.  
Studies in adults are limited and inconclusive. Van den Heuvel et al. found that 
males aged 20–30 y did not experience improved calcium absorption after 21 d with 15 
g/d inulin, frutooligosaccharides, or galactooligosaccharides. However, calcium 
absorption was measured over 24 hours after the dose was received. Since then, it has 
been determined that calcium absorption is most impacted by fermentable carbohydrates 
between 24 and 36 hours after dose, implying a lower gut effect. Taking this into account, 
van den Heuvel et al. assessed the impact of 15 g/d fructooligosaccharides (FOS) for 9 
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days on adolescent males and found that it increased calcium absorption. It is unclear if 
the methodological or age discrepancies were responsible for the conflicting results. 
Several studies have demonstrated that calcium absorption is enhanced by dietary 
fermentable carbohydrates in ovariectomized (OVX) rats, the FDA-approved animal 
model for postmenopausal women. For example, FOS improves calcium absorption and 
reduces ovariectomy-induced bone loss (24, 25). Additionally, SYN1 improves calcium 
absorption and reduces ovariectomy-induced bone loss (26, 27). Polydextrose (PDX) has 
also been shown to improve calcium absorption (26) and promote bone quality in the 
OVX model (24). Mitamura et al. (28, 29) showed that OVX rats experienced increased 
calcium absorption with either 3% raffinose or 5% soluble soybean fiber diets for 4 
weeks. 
Fermentable carbohydrates have also been shown to increase calcium absorption 
and improve bone status in non-OVX rat models. Inulin was shown to improve short-
term calcium absorption in male rats fed low- and high-calcium diets and to improve 
long-term calcium absorption for rats on low-calcium diets (30, 31). Inulin was also 
shown to improve total body BMC and BMD in growing male rats on low-, adequate-, 
and high-calcium diets across all ages, up to 22 weeks old (32). Similarly, a 5% FOS diet 
improved calcium balance and true calcium absorption after 15 days in 2-month-old male 
rats (33). One study comparing the effectiveness of inulin and FOS in growing rats over a 
3-month period found that both increased total body BMC, tibial BMD, and calcium 
transporter calbindin D9k, and decreased resorption marker CTx. However, the effect on 
bone, calbindin D9k, and CTx was greater in the inulin group than in the FOS group (34). 
In a survey of eight different fibers, including inulin and the inulin/FOS mixture SYN1, 
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only SCF and soluble fiber dextrin improved peak breaking force of the femur after 12 
weeks of feeding (3). A diet including up to 8% galactooligosaccharides was also shown 
to improve calcium absorption in 4-week-old male rats in a dose-dependent manner (35). 
Other dietary interventions for decreasing risk of osteoporotic fracture include 
flavonoids. Soy Isoflavones, which share structural similarity to estrogen, have been the 
most prevalently studied flavonoids for bone health. RCTs assessing the effect of isolated 
soy isoflavones on BMD have been fairly mixed, showing short-term efficacy in reducing 
postmenopausal bone loss but little effect in interventions at least 2 years long (36). 
However, BMD is only one predictor of fracture, and flavonoid interventions may be 
influencing other factors, such as bone composition and architecture. Weaver et al (7), 
using 
41
Ca methodology, showed that soy cotyledon and germ effectively increased bone 
calcium retention in postmenopausal women over a 50-day period by 9% and 5%, 
respectively; however, this was a short-term study. Plum, high in the flavonoid rutin, has 
also been assessed as an intervention for improving bone quality in postmenopausal 
women. One randomized, controlled trial (37) found that postmenopausal women 
consuming 100 g/d plum for 1 year improved BMD in the ulna and spine. Other 
flavonoid-containing fruits and vegetables, like blueberry (38), onion (39), and 
mushroom (40), have been shown to be bone protective in OVX rats, but their efficacy in 




Ca methodology has several advantages. 
41
Ca is a virtually stable, long-
lived radioisotope (t1/2 = 10
5
 years) that can be measured with great precision and 
sensitivity via AMS. Intervention effects on bone balance can be detected within 4–8 
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weeks, whereas studies relying on DXA require about 2 years (41). Lee et al. (42) found 
that a 14% decrease in 
41
Ca resulted in a positive bone balance of 100 mg/d Ca. By 
interpolation, a 7% decrease in Ca
41
, as observed in the present study, would result in a 
positive bone balance of approximately 50 mg/d Ca. If the entire effect of SCF is 
observed in 50 days, then 2.5g bone calcium, or 0.3% TBBMC, would be protected. 
However, if the effect persisted chronically, it would result in an increased balance of 
18.25g bone calcium, or 2.5% TBBMC, per year. This effect would easily be detectable 
by DXA. 
We observed a significant increase in the bone formation marker BAP between 
placebo and the 20 g/d SCF intervention. The magnitude of this difference was similar to 
the observed reduction in bone calcium loss. We detected no effect of SCF on bone 
resorption marker NTx. This contrasts with previous studies predicting that fermentable 
carbohydrates would reduce bone resorption (12, 14, 27). Zafar et al. (27) showed that 
SYN1-supplemented OVX rats had a net increase in calcium balance, but experienced 
both reduced bone formation and resorption, as measured by calcium kinetics.  Our 
results indicate that bone formation may play a greater role in prebiotics-related bone 
protection than previously thought; however, high intrapersonal variation of bone 
turnover markers (43) warrant cautious interpretation pending confirmation in future 
studies. 
Our participants’ pre-study, baseline, and washout total fiber intakes were about 
18 g/d, which is higher than the reported average adult fiber intake of 14.8 g/d in the US 
(44) but still lower than recommended for adult women (25 g/d) (45). Average total fiber 
intake during the placebo phase dropped to 14.2 g/d and, without including the fiber 
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contributed by the intervention, remained at approximately the same level during 10 g/d 
and 20 g/d SCF phases. The decrease was wholly due to displacement of fiber-rich foods 
by the muffin intervention. Addition of SCF brought total fiber consumed to 20.4 g/d and 
30.9 g/d during the moderate- and high-dose phases, respectively. Soluble fiber followed 
a similar trend, dropping slightly from about 5.5 g/d in self-selected diet during 
nonintervention periods, to about 4.5 g/d during intervention periods. SCF 
supplementation dramatically increased the amount of soluble fiber consumed during the 
10 g/d and 20 g/d SCF phases to 13.2 g/d and 21.3 g/d, respectively (Table 5.2).  
Even during the high-fiber phase, participants in this study reported low severity 
and occurrence of gastrointestinal distress. This is not surprising, as adolescents tolerated 
12 g/d SCF well (4), and adults tolerated large bolus doses (40 g SCF) and even larger 
divided doses (65 g SCF) well (46). The tolerability and high compliance rate we 
observed indicate that SCF supplementation appears to be a reasonable way to increase 
bone retention while improving fiber intake in most postmenopausal women. 
This study has several strengths. The strong randomized-order, crossover design 
eliminated many confounding variables. The 
41
Ca methodology measures bone loss in a 
relatively short time period. Participants were also free living and on self-selected diets, 
making the results translatable to the public. Limitations exist in this study as well. We 
used a small, convenient sample, decreasing the generalizability. We did not measure 
calcium absorption in this study, so we cannot determine the mechanism by which SCF 
reduced bone loss. Another limitation is the short 50-day intervention length. While 
41
Ca 
methodology is rapid and sensitive enough to detect changes in bone retention in this 
period of time (7, 41), we were not able to assess whether the effect of SCF is persistent 
55 
 
or would diminish with long-term chronic feeding. One complete bone-turnover cycle is 
about 120 days, well over two times the duration of each intervention. 
Chronic doses of 10 g/d and 20 g/d SCF were well tolerated by participants, and 
increased bone calcium retention in free-living postmenopausal women in a dose-
dependent manner. Further research is necessary to determine the mechanism driving 
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4. EFFECTS OF EXPOSURE TO CHRONIC INCREASE IN CECAL SHORT-






Several prebiotics have been shown to improve calcium absorption in adolescents, 
postmenopausal women, and rodent models. In this study, we aimed to assess the effect 
of a product of prebiotic fermentation, short-chain fatty acids (SCFAs), on calcium 
absorption. Rats were randomized to receive 0, 300, or 600 uL of a SCFA mixture twice 
daily for 11 days. Calcium absorption was measured on the 12
th
 day. No significant 
differences in calcium absorption were detected among the three groups. Cecal weight 
was significantly increased due to SCFA supplementation (0 vs 300uL SCFA, p = 0.034).   
4.2 Introduction 
Calcium is the major mineral constituent in bone and a critical life-sustaining 
micronutrient, yet due to scarcity and diet choices, insufficient calcium intake is a 
common problem worldwide (1). Thus, novel methods to enhance calcium absorption, 
which is only about 30% from a single serving of dairy or a 300 mg calcium supplement 
when consumed by postmenopausal women, are being explored. One method for 
enhancing calcium absorption is the consumption of prebiotics. These nondigestible, 
fermentable carbohydrates—including fructooligosaccharides (FOS), 
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galactooligosaccharides (GOS), soluble corn fiber (SCF), and others—have been shown 
to improve calcium absorption in adolescents (2-7) and postmenopausal women (8-10). 
 These carbohydrates pass through the majority of the gastrointestinal tract and 
reach the colon intact, where they are metabolized by gut microbiota. Gut microbiota, 
which constitute approximately 95% of the cells in the human body, break down these 
carbohydrates through saccharolytic fermentation, primarily into short-chain fatty acids 
(SCFAs), especially acetate, propionate, and butyrate (11). Enhanced calcium absorption 
in humans is observed 24–36h after calcium consumption, which indicates absorption 
occurs in the large intestine (3, 7). 
It has been hypothesized that the production of SCFAs decreases colonic pH, 
which in turn ionizes and solubilizes additional calcium, enabling higher rates of 
paracellular calcium diffusion (12, 13). Several rat studies demonstrated that feeding 
prebiotics decreases cecal or colonic pH in addition to increasing calcium absorption (14-
18). However, one study showed ex vivo that rat colon and cecal segments had improved 
calcium absorption due to increased luminal SCFA concentration, but not when HCl was 
used to depress luminal pH, indicating that SCFAs do not improve calcium absorption 
solely by  reducing luminal pH (19). This study was designed to assess the effect of 
chronically heightened cecal and colorectal SCFA concentration on calcium absorption in 




4.3.1 Study Design 
Twenty 3-month-old rats were implanted with cecal catheters (100% silicone 
Silastic® laboratory tubing; 0.51mm I.D. x 0.94mm O.D.) under anesthesia (isoflurane). 
On the third day, after two days of recovery, the rats entered the treatment phase of the 
study. For 10 days, the rats received two treatment doses directly infused into their ceca 
approximately 12 h apart, at a rate of 100 uL/s. On the ninth day of treatment, at least 2 h 
after receiving the morning dose, all the rats underwent surgery and had jugular catheters 
implanted (100% silicone Silastic® laboratory tubing; 0.51 mm I.D. x 0.94 mm O.D.). 
After a 2-day recovery, following their final treatment dose, the rats were fasted for at 
least 8 h. The following morning, each rat received a 1 mL cecal dose of calcium 
ascorbate (316g; 32.4g Ca) and saline. They also received a trace amount of 
45
Ca either 
intravenously (10 uCi) or with the cecal calcium infusion (20 uCi). One hundred and 
seventy uL blood samples were collected at 0, 60, 120, 180, 240, 330, 420, 540, 720, 900, 
1260, and 1440 min after dosing.  A 100-uL plasma aliquot was collected from each 
blood sample and counted in a liquid scintillation analyzer (Tri-Carb 2910TR; 
PerkinElmer). Urine samples were collected as 0–1440 min bulk samples. These were 
also measured for radioactivity using the liquid scintillation analyzer. 
Plasma 
45
Ca concentration from half of the rats from each group was used to 
calculate absorption efficiency with the Win-SAAM (Simulation Analysis and Modeling) 
program as previously described (20). A multicompartmental calcium model was created 
and plasma 
45
Ca data was fitted to it. Plasma 
45
Ca data from IV-dosed rats was used to 
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establish calcium transfer rates among blood, bone, exchangeable calcium pools, and 
calcium clearance. Plasma 
45
Ca data from cecum dosed rats was used to establish calcium 
absorption, based on calcium transfer rates established by the IV plasma data. Urinary 
45
Ca provided additional data for constructing the model. 
Plasma 
45
Ca appearance from all of the rats was used to assess calcium absorption 
via area under the curve. 
4.3.2 Treatments 
Each of the rats received one of three treatments twice daily: 0 (Placebo; PLC), 
300 (Low Dose; LOW), or 600 (High Dose; HIGH) umol SCFA mixture. The amount of 
SCFA provided in a single HIGH dose is about equal to the total amount found in cecum 
of a control rat in other studies assessing the effectiveness of fibers to increase calcium 
absorption (21, 22). Therefore, it was expected that the amount of SCFAs contained in 
the ceca of HIGH group rats would be doubled at each dosing period. Fiber supplemented 
rats have increased cecal SCFA concentration up to around 50%, compared to control. 
The SCFA mixtures were comprised of the molar ratio 5-mol sodium acetate, to 2-mol 
sodium propionate, to 1-mol sodium butyrate. This is approximately the same ratio as has 
been observed in rodent ceca when on prebiotic-containing diets. 
4.3.3 Cecal Analysis 
The animals were euthanized after the calcium kinetics test and their ceca were 
collected. The cecum was weighed before and after thoroughly rinsing with saline. Cecal 
content weight and pH (ThermoWorks®; pH Spear) were measured. 
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4.3.4 Statistical Analysis 
ANOVA was performed with Student’s t-test using SAS (SAS 9.3; SAS Institute) 
to determine statistical significance of calcium absorption, cecal pH, and weights among 
treatment groups. Statistical significance was set at p ≤ 0.05.  
4.4 Results 
Significant differences were detected in neither fractional calcium absorption 
among treatment groups (CON vs LOW: p = 0.203; CON vs HIGH: p = 0.915; LOW vs 
HIGH p = 0.129), nor area under the curve (CON vs LOW: p = 0.476; CON vs HIGH: p 
= 0.487) as determined by plasma 
45
Ca appearance. Likewise, no significant differences 
were detected among treatment groups in rodent body weight, cecal pH, or cecal content 
weight. A statistically significant difference in cecal weight was detected between the 
CON and LOW groups (p = 0.034), while a trend for significance was detected between 




Figure 4.1: Plasma Appearance of 
45
Ca is Unaffected by Chronic SCFA-Salt Dosing 
Table 4.1: Rat Body Weight, Cecal pH, and Cecal Content Weights at Sacrifice 
(Mean ± SD) 
Group Body Weight (g) Cecal pH Cecal Content Weight (g) 
CON 384.5 ± 12.0 6.32 ± 0.15 4.23 ± 0.67 
LOW 385.7 ± 27.3 6.21 ± 0.13 4.98 ± 1.44 
HIGH 391.6 ± 21.2 6.39 ± 0.11 4.18 ± 0.45 
 
 
Figure 4.2: Rat Cecal Wall Weight at Sacrifice by Dose 



































No significant differences were detected in plasma 45Ca appearance among groups, 
























4.5 Discussion  
Our results failed to show an increase in calcium absorption in the large intestine 
with a chronic increase in cecal SCFA concentration. This indicates that one or more of 
the mechanisms proposed with fermentable carbohydrates to increase calcium absorption 
was not demonstrated in this study. There are several explanations that could be related to 
a lack of real effect or to a failure in the study design to test the effect of SCFA on 
calcium absorption. 
SCFAs may improve calcium absorption through proton exchange. Protonated 
SCFAs are absorbed into colonocytes through concentration-dependent non-ionic 
diffusion. The transported hydrogens may then be exchanged back into the lumen for 
calcium (23). SCFAs have been shown to improve short-term calcium absorption in the 
distal colon of humans (23) and rats (24) during an enema or a luminal perfusion, 
respectively. In the present study, SCFAs were administered chronically in the cecum and 
were not administered at or near the same time as calcium kinetics were assessed. In 
agreement with previous work (25), showing a delay compartment between calcium 
absorption sites in the small and large intestine, our calcium kinetics data indicate that 
calcium was dosed into a compartment preceding the absorption site. Absorption likely 
occurs in the colon rather than in the cecum. A mixture of long- and short-chain fructan-
type fibers was more effective at improving calcium absorption than only FOS (4), 
indicating that fermentation along the length of the colon might be more effective at 
improving calcium absorption than rapid fermentation at the beginning of the colon. 
Also, the calcium and 
45
Ca tracer dosing was 12 h after the last SCFA dosing. The 
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majority of the SCFAs may have already been absorbed and metabolized and could 
therefore have been unavailable for exchange in any part of the large intestine. 
As previously discussed, a decrease in pH due to SCFA production may drive 
calcium absorption. As cecal and colonic pH decreases, calcium may be further 
solubilized, leading to increased para- and trans-cellular diffusion. In the present study, 
neither cecal pH nor calcium absorption were not affected by SCFA-salt dosing.  
Decreased pH may play a greater role in calcium absorption if calcium inhibitors 
are present in the diet. Calcium absorption inhibitors, such as oxalate and phytate, are 
common in many foods and reduce the bioavailability of minerals, including calcium. 
Lopez et al. (26) found that rats fed phytase and FOS had less phytate excretion than rats 
fed phytase alone, suggesting that FOS fermentation may improve phytate degredation in 
the large intestine. This would release any minerals bound to the phytate at the time of 
fermentation. Wang et al. (27) showed that calcium absorption was restored in rats fed a 
phytate-containing diet when they were also fed FOS. 
There are several proposed mechanisms in addition to the pH-calcium-solubility 
hypothesis. Prebiotic fibers have a relatively high water binding capacity, and since they 
remain intact until the colon, they bring water with them. With an increased solvent pool, 
a greater proportion of minerals can dissolve and may be more easily absorbed. 
Incorporation of dietary fermentable fibers leads to greater amounts of cecal soluble 
calcium and blood flow (13). 
Another hypothesis is that fibers enhance calcium absorption through cecal 
hypertrophy. Dietary fermentable fibers significantly increase cecal wall weight in rats 
(13, 27, 28). Butyrate is the preferred energy source of colonocytes, likely contributing to 
69 
 
enterocyte proliferation (29). Cecal and colorectal hypertrophy would increase surface 
area available for both paracellular and transcellular calcium absorption. In one study, 
GOS supplementation increased wet and dry stool weight in sham and gastrectomized 
rats (30), indicating an increased excretion of non-water mass, potentially through cell 
sloughing or intact GOS. In another study, GOS supplementation (31) was not well 
correlated with an increase in stool moisture content. Weaver et al. (21) found a 
significant relationship between SCFA production and cecal content weight (p < 0.05). It 
is unclear if this increase was caused from cecal hypertrophy, water-holding capacity of 
the fermentable carbohydrates, or both. The present study showed that chronic SCFA-salt 
administration increased cecal wall weight, suggesting increased proliferation. This was 
not paired with an increase in calcium absorption. 
Prebiotic fermentation products may increase calcium transporters in the colon, 
resulting in increased calcium absorption. FOS supplementation increases rat cecal and 
colorectal levels of the calcium transporter calcium-binding protein calbindin-D9k, along 
with increasing calcium absorption (32, 33). Additionally, factors regulating calbindin-
D9k transcription, CDX2 and Vitamin D-receptor (VDR), were significantly increased in 
the colorectal segments of rats on a FOS supplemented diet, potentially increasing 
transcellular calcium absorption (34). Another study (35) found that Caco-2 cells cultured 
with sodium propionate and sodium butyrate developed greater levels of calbindin-D9k, a 
calcium transporter. In MCF-7 cells, SCFA concentration increased intracellular calcium 
concentration dose dependently, contingent on GPR43 activity (36). GPR43 was also 
activated by SCFAs in mice colonocytes, though neither calcium absorption nor 
concentration was not measured (37). GPR43 is expressed in human colonocytes (38), 
70 
 
and these models may be providing some insight into prebiotic-enhanced calcium 
absorption. 
Another way that prebiotics may alter calcium absorption is through the 
promotion of specific gut microbiota. Several studies have shown shifts in gut microbial 
populations after adding fermentable carbohydrates to the diet, generally showing an 
increase in carbohydrate-fermenting organisms (3, 6, 39). However, the mechanism by 
which these bacteria would enhance calcium absorption is still unclear. It is possible that 
they work through the mechanisms listed above. Probiotic supplementation 
(Bifidobacterium bifidum and Bifidobacterium longum), GOS supplementation, and 
synbiotic supplementation (probiotic and GOS) in rats for 30 days increased tibia and 
femur calcium content, proximal-colon crypt depth and cell density, and apparent 
calcium absorption (17, 31). At the very least, gut microbiota appear to impact calcium 
absorption efficiency in the colon, since it was shown that antibiotics reduce the calcium 
absorption benefit provided by GOS (40). 
In summary, a chronic increase in cecal SCFA salt concentration alone does not 
appear to influence calcium absorption using this protocol. Using the acidic form of 
SCFAs, dosing SCFA salts just prior to dosing Ca, or challenging calcium absorption 
with inhibitors may be necessary for the mechanism by which prebiotics increase calcium 
absorption. There are still several potential mechanisms by which fiber could increase 
calcium absorption that have yet to be examined directly.  
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Bone health becomes increasingly important as age progresses and bone 
demineralization outpaces bone formation. This is particularly important for females, 
who experience a drastic change in sex hormones at menopause, resulting in increased 
bone resorption and fracture risk during their postmenopausal years. Yet consumption of 
calcium, the primary constituent of bone, remains below recommended levels for this 
demographic (1). Efforts to ameliorate bone loss include the use of fermentable 
carbohydrates.   
Fermentable carbohydrates improve bone health in OVX rats, the approved model 
of postmenopausal women. In this model, calcium absorption has been shown to be 
enhanced by fructooligosaccharides (FOS)(2-4), a fructooligosaccharide-inulin mixture 
(SYN1)(5), polydextrose (PDX)(5), and raffinose (6). 
Effectiveness of fermentable nondigestible carbohydrates in enhancing bone 
metabolism in postmenopausal women has not been as clear. While SYN1 (7), 
transgalactooligosaccharides(8), and lactulose (9) improved calcium absorption in 
postmenopausal women, scFOS did not (10, 11). This difference could have been due to 
the type of fiber, size of dose, length of trial, or sensitivity of method used. The present 
study showed, using the sensitive novel 
41
Ca method, that SCF reduces bone loss in 
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postmenopausal women in a dose-dependent manner. It is estimated that consuming 20 
g/d SCF would improve net bone calcium balance by 50 mg/d Ca. 
Understanding the mechanism by which these carbohydrates improve calcium 
metabolism could enhance efforts to reduce fracture risk in all populations and should be 
investigated. The present study of SCFAs in rodents shows that a chronic increase in 
cecum concentrations of SCFAs does not increase calcium absorption. Other mechanisms 
should be explored further, such as depressed pH in and out of the presence of calcium 
inhibitors, or the selective feeding of gut microbiota. 
5.1 Future Work 
5.1.1 The Effectiveness of SCF in Postmenopausal Women: 
The present study with postmenopausal women showed that SCF improved bone 
calcium retention over a 50-day period; however, postmenopausal women are at a high 
risk of fracture for much longer—that is, for the rest of their lives. Therefore, SCF should 
be assessed for its effectiveness as a long-term intervention for improving bone health in 
postmenopausal women. Abrams et al. (12) found that chronic dosing of SYN1 improved 
both calcium absorption and BMD in adolescents after 1 year, and Coudray et al. (13) 
found that inulin improved calcium absorption after 1 year in male rats with low calcium 
intake, but further study is necessary. DXA, the recognized gold standard of bone health 
measurement, and the sensitive 
41
Ca methodology of bone calcium assessment, should 




5.1.2 Calcium-Absorption Enhancement Mechanism  
Many studies show that calcium absorption is enhanced with dietary 
supplementation with fermentable fibers, but few assess the mechanism driving this 
effect. The present investigation on chronic SCFA dosing in rats provides a framework 
for assessing this mechanism by singling out one of the effects of dietary fibers. Other 
effects of fibers should be assessed directly for their abilities to affect calcium absorption. 
The fermentation of nondigestible fibers into SCFAs decreases culture pH in vitro 
(14) , and may decrease the pH of the large intestine in vivo, leading to increased calcium 
solubility. Increased concentration of solubilized calcium may increase passive diffusion 
of calcium across the wall of the large intestine. Therefore, the effect of luminal pH on 
calcium absorption should be directly assessed. Ex vivo, calcium absorption in a segment 
of large intestine was enhanced by SCFA concentration, but not by a decrease in pH by 
HCl (15), however, the present study showed that chronically increasing the 
concentration of cecal SCFA-conjugate bases does not improve calcium absorption in 
vivo when there is an exposure gap between SCFA and 
45
Ca exposure. The observed 
difference in the effectiveness of SCFAs to improve calcium absorption could be 
attributed to the exposure gap, model (i.e. ex vivo vs in vivo), intestinal segment, study 
duration, or the acidity of the SCFAs used. Therefore, future studies should assess these 
differences.  
Similarly, increasing the acidity of the large intestine could free calcium bound to 
common calcium absorption inhibitors, such as phytate and oxalate, and thus increase 
calcium bioavailability. Future research should explore this relationship.   
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A study to determine the effect of soluble corn fiber on bone resorption in post-menopausal 
women  
Post-menopausal women are needed for a calcium study in the Department of Nutrition 
Science. It is an 18 month study which involves consuming soluble corn fiber snack products for 
three phases, each 50 days long. Researchers will study how fiber may influence the amount of 
calcium absorbed in bones.  
Maximum total compensation for completing the entire study is $825.   
Eligibility requirements include: healthy, post-menopausal women who are at least 4 years past 
the onset of menopause due to natural menopause or total hysterectomy, not currently taking 
estrogen replacement therapy or treatment for osteoporosis.  
For more information, contact Berdine Martin at martinb1@purdue.edu 49-46559 or 49-40385.  
The principal investigator is Connie Weaver, distinguished professor and head of the 







































Things to know about your Baseline Visit: 
 Baseline visits will be held in Stone Hall. If you don’t have a campus parking pass, we will 
be able to provide you with an A-pass. Please let us know ahead of time so you will have 
it prior to your visit.  
o There are A parking spots behind Smith Hall, on Russell St, parking garage, etc. 
 We will meet you in Stone Hall, Room 124, at the time of your scheduled appointment. 
Please enter and have a seat in the waiting area.   There have been a few minor changes 
to the protocol. We will review those and have you sign the new consent form. 
 At your visit, we will need you to be prepared to collect fasting urine and fasting blood 
samples. This means that we ask you not to eat or drink anything but water for at least 8 
hours before your visit.  
 We will also complete a DXA scan to measure bone mineral density. Since this is an X-
ray, you cannot wear any metal during the scan (clothing with zippers, eyelets, hooks or 
jewelry, etc). We advise you to wear comfortable clothing to make the scan faster and 
easier. We will have scrubs available for you to change to if you forget.  
 Bring with your schedule/calendar for us to go over and verify urine collection dates 
with you. If you have any special dates when you will be on vacation or unavailable bring 
them with so we can plan around them.  
 This visit will probably take approximately 45 minutes. 




Text for instructions after Visit 0 
Send as e-mail 
 
Thank you for coming for your baseline visit this morning.  It is good to get this study started and 
we really appreciate your help.  I just want to review the details that we covered this morning so 
you have them in writing and you can transfer them to your calendar. 
 
First of all you will be collecting urine every 10 days from now until your next visit.  The dates 
which we decided would fit your calendar are the following.  Remember to collect after the first 
void of the morning and including the first void of the following morning.  Place the bottles in 
the cooler that we provided and please set it on your porch.  I will come by sometime before 
noon to pick it up and I will leave you another cooler.  Unless you contact me I will assume that 
you will be true to your schedule so you don’t need to contact me every time you collect urine.  
If however, you forget please let me know that you are collecting on the following day so I can 
rearrange my collection schedule.  The last collection you will bring with you when you come the 
following day for your clinical visit. 
 






Collection 5:   
 
Now for the fecal collections!   
The timing for fecal collections during the baseline period is as follows: 
You will collect the first specimen sometime during the first week of the baseline phase (          ) 
During the last week of the baseline phase you will collect 3 specimens (                   ) 
 
Each time you collect a specimen please send me an e-mail or call me (see info below) and leave 
me a message.  Place the sample in the small cooler with the ice pack and set it out so that I can 
pick it up.   
 
If you have any questions please feel free to contact me. 
 
Again we really appreciate your cooperation with this study.  You should be receiving the $50 





Instructions for Consumption of Muffins and Drinks 
 
1.  Each muffin and drink bottle contains equal amounts of fiber. (0-10 
g) 
2. Please consume 1 muffin each day.  Please keep all muffins frozen 
as they are very moist and can accumulate mold very easily at room 
temperature.  Follow the instructions and take the muffin out of 
the freezer the night before and put it in the refrigerator to thaw 
for the next day. 
3. Fill the bottle with normal tap water and drink one each day.  You 
may choose to vary the amount of water that you add due to 
variation in flavor.  However, please add enough so that all 
contents are dissolved and no “sludge” is left in the bottom. 
4. Please record each event on your compliance record. 
5. Do not consume both products at the same time as high amounts of 
fiber consumed at the same time could result in GI symptoms.   
6. Please double check us and make sure that the same number and 
color is on each of the products that we give you.  
 
 





1.  We cannot diagnose osteoporosis or osteopenia 
2. Explain total body chart first. 
Definitions: 
 BMD : Bone Mineral Density  (g mineral per cm2 bone area) 
 BMC:-  g mineral in that bone 
 YA T-score:  a T score of 0 means your BMD is equal to the 
norm for a healthy young adult .  A T-score between +1 and -1 is 
considered normal.  A T-score between -1 and -2.5 indicates that 
you have low bone mass. 
 Age matched Z score:  your measurement compared to that 
of women your age and weight. 
 Lines on colored chart are mean ± 1 SD of age matched Z 
score 










TL41   Visit 1  Check sheet 
1.  _____  Verify Fasting Status 
2.  _____  Verify Medical Status, Review Screening Form 
3.  _____  Receive  Diet Record  
4.  _____  Receive Compliance Calendar 
5.  _____  Explain DXA results ( see Explanation of DXA) 
6.  _____  Explain muffin and drink protocol (see Instructions for 
Muffins and Drinks) 
7.  _____  Explain symptom sheet (deliver with 1st and 3rd urine pick 
up) 
8.  _____  Collect Fasting urine 
9.  _____  Collect Fasting Blood  (Fill out Request form for Doug) 
10. _____  Deliver Muffins and record quantity 
11. _____  Deliver Drinks and record quantity 
12. _____  Make plan for delivery of additional muffins and drinks 
(preferable to deliver the rest of the products at the time we pick 
up the second urine collection but depends on how many muffins 
they can store) 
13. _____  Review dates for urine collection and next appointment 
(note any changes from original planned dates)  
14. _____  Review Compliance Record Sheet 
15. _____  Deliver additional urine bottles if necessary  





















































Table A.1 Bone Biomarker Concentrations 
 ID  Phase BAP (U/L) OC (ng/ml) NTx (nM BCE/mMol Cr) 
200 1 27.89 6.17 28.76 
200 2 25.20 6.64 36.47 
200 3 26.78 7.07 28.01 
200 4 21.97 8.46 25.51 
200 5 23.28 7.03 41.70 
200 6 23.70 6.31 36.71 
200 7 22.27 7.59 33.35 
201 1 37.28 9.31 80.81 
201 2 43.75 8.15 86.20 
201 3 51.70 12.36 n/a 
201 4 44.41 15.63 76.69 
201 5 40.49 13.86 41.06 
201 6 39.00 10.60 53.49 
201 7 41.03 11.13 25.77 
202 1 22.52 7.92 22.48 
202 2 31.79 7.63 29.41 
202 3 27.03 4.94 35.81 
202 4 37.37 7.31 31.24 
202 5 25.82 9.06 32.11 
202 6 27.22 8.80 32.53 
202 7 n/a n/a n/a 
204 1 24.28 12.57 68.25 
204 2 23.16 11.65 88.26 
204 3 23.40 14.20 92.72 
204 4 30.11 15.10 64.22 
204 5 36.81 13.79 98.55 
204 6 24.91 13.48 37.43 
204 7 25.93 7.38 76.40 
205 1 34.36 11.15 54.26 
205 2 28.18 12.10 62.06 
205 3 34.16 13.42 80.77 
205 4 30.77 11.26 36.41 
205 5 28.31 11.76 n/a 
205 6 25.94 12.52 45.09 
205 7 26.17 9.68 57.14 
206 1 28.08 4.26 16.30 
206 2 30.96 4.19 29.08 
206 3 28.81 5.57 18.54 
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 ID  Phase BAP (U/L) OC (ng/ml) NTx (nM BCE/mMol Cr) 
206 4 31.94 5.54 24.46 
206 5 28.90 5.40 46.43 
206 6 33.69 5.67 35.08 
206 7 33.17 5.88 32.13 
208 1 35.72 11.54 40.91 
208 2 40.30 12.08 48.38 
208 3 36.77 9.46 44.49 
208 4 34.20 10.86 51.11 
208 5 35.80 9.77 39.39 
208 6 34.41 n/a 98.95 
208 7 33.98 n/a 47.65 
209 1 21.16 10.01 54.68 
209 2 23.72 10.93 54.87 
209 3 21.51 10.62 59.44 
209 4 22.45 11.80 61.57 
209 5 21.60 10.66 55.80 
209 6 22.89 9.64 40.69 
209 7 22.98 10.30 59.30 
210 1 22.05 7.07 33.29 
210 2 21.33 7.45 27.58 
210 3 20.94 8.62 28.14 
210 4 23.94 7.46 29.46 
210 5 21.51 6.01 31.26 
210 6 21.11 8.55 23.02 
210 7 23.59 8.13 37.84 
211 1 30.83 13.35 100.32 
211 2 29.11 12.34 70.13 
211 3 45.63 19.38 73.33 
211 4 29.37 12.64 69.48 
211 5 27.52 12.98 95.54 
211 6 28.71 9.47 73.17 
211 7 23.90 10.17 63.23 
213 1 36.38 15.34 93.99 
213 2 29.43 12.79 n/a 
213 3 37.72 15.38 135.18 
213 4 35.96 14.33 92.43 
213 5 33.65 15.65 64.89 
213 6 36.61 16.24 64.57 
213 7 33.26 14.41 48.78 
214 1 26.97 13.00 47.67 
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 ID  Phase BAP (U/L) OC (ng/ml) NTx (nM BCE/mMol Cr) 
214 2 25.83 13.06 56.18 
214 3 18.70 12.13 48.58 
214 4 30.11 10.35 56.33 
214 5 27.25 14.36 41.73 
214 6 29.79 12.93 40.88 
214 7 26.57 10.41 35.14 
218 1 18.49 8.83 64.84 
218 2 17.71 12.99 43.10 
218 3 19.46 8.11 57.56 
218 4 18.49 9.56 50.98 
218 5 17.93 9.04 46.09 
218 6 18.83 9.86 44.81 
218 7 18.23 7.61 45.04 
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200 U0.1 Baseline 108.00 4.042 0.176 1783.0 0.784 
200 U0.2 Baseline 118 3.411 0.083 2021.2 0.4987 
200 U0.3 Baseline 129 3.012 0.173 1383.9 1.194 
200 U0.4 Baseline 137 2.766 0.079 1830.4 0.7999 
200 U0.5 Baseline 147 2.499 0.087 1959.1 0.8401 
200 U1.1 843 158 2.325 0.106 2135.0 0.8075 
200 U1.2 843 168 2.418 0.069 2580.3 0.5274 
200 U1.3 843 178 1.990 0.063 1765.8 0.6464 
200 U1.4 843 187 1.937 0.095 2613.0 0.5264 
200 U1.5 843 198 1.733 0.079 1648.9 0.8097 
200 U2.1 R1 209 1.713 0.056 1172.4 1.7263 
200 U2.2 R1 222 1.809 0.107 1936.1 0.5947 
200 U2.3 R1 229 1.793 0.063 1348.8 1.0529 
200 U2.4 R1 239 1.560 0.049 1655.7 0.7218 
200 U2.5 R1 248 1.460 0.045 1364.8 1.1531 
200 U3.1 709 260 1.369 0.051 2024.7 0.5355 
200 U3.2 709 269 low current low current 938.0 1.9424 
200 U3.3 709 278 1.312 0.042 1326.3 1.1859 
200 U3.4 709 289 1.300 0.042 2366.8 0.5519 
200 U3.4 709 298 1.388 0.052 2018.2 0.6477 
200 U4.1 R2 309 1.398 0.053 1959.4 0.7827 
200 U4.2 R2 319 1.534 0.062 1170.9 1.1728 
200 U4.3 R2 328 1.290 0.060 1468.4 1.1309 
200 U4.4 R2 338 1.342 0.053 1510.1 0.8999 
200 U4.5 R2 353 1.349 0.052 1670.5 0.766 
200 U5.1 576 362 1.370 0.057 2142.7 0.5471 
200 U5.2 576 372 1.336 0.089 2473.2 0.41 
200 U5.3 576 381 1.314 0.056 1298.6 1.1624 
200 U5.4 576 392 1.251 0.059 1454.2 1.2169 
200 U5.5 576 401 1.300 0.052 1756.7 0.6389 
200 U6.1 R3 413 1.562 0.039 1687.5 0.5625 
200 U6.2 R3 423 1.319 0.052 1576.7 0.7077 
200 U6.3 R3 431 1.444 0.049 1455.8 1.3742 
200 U6.4 R3 441 1.512 0.063 1523.8 1.1524 



















201 U0.1 Baseline 111 4.781 0.198 587.3 0.9829 
201 U0.2 Baseline 120 4.088 0.175 709.1 0.5951 
201 U0.3 Baseline 129 3.667 0.135 680.9 0.2783 
201 U0.4 Baseline 139 3.117 0.129 647.0 0.7892 
201 U0.5 Baseline 149 3.104 0.079 243.2 0.5962 
201 U1.1 709 160 2.389 0.097 884.8 0.1 
201 U1.2 709 170 2.803 0.135 364.9 0.1953 
201 U1.3 709 179 2.134 0.063 583.6 1.0441 
201 U1.4 709 189 1.990 0.067 976.4 0.0 
201 U1.5 709 203 2.257 0.067 190.3 0.5837 
201 U2.1 R1 214 2.246 0.121 1030.8 0.1 
201 U2.2 R1 225 1.816 0.051 644.3 0.7625 
201 U2.3 R1 231 1.870 0.057 414.5 0.5226 
201 U2.4 R1 244 1.503 0.060 710.0 0.1 
201 U2.5 R1 255 1.750 0.055 1275.9 0.1711 
201 U3.1 843 273 1.510 0.044 592.5 0.3028 
201 U3.2 843 280 1.515 0.034 1646.1 0.2927 
201 U3.3 843 293 1.626 0.080 565.1 0.5297 
201 U3.4 843 303 1.619 0.045 323.8 0.5954 
201 U3.5 843 310 1.676 0.073 324.2 0.6058 
201 U4.1 R2 324 1.562 0.061 1011.6 0.2281 
201 U4.2 R2 332 1.423 0.064 751.0 0.6484 
201 U4.3 R2 341 1.486 0.050 1172.4 0.3439 
201 U4.4 R2 354 1.485 0.096 519.5 0.5 
201 U4.5 R2 364 1.452 0.239 572.4 0.3203 
201 U5.1 576 379 1.521 0.053 416.4 0.9302 
201 U5.2 576 389 1.486 0.060 936.9 0.4507 
201 U5.3 576 401 1.596 0.054 272.0 0.3243 
201 U5.4 576 409 1.691 0.034 291.0 0.1541 
201 U5.5 576 419 1.636 0.036 944.4 0.3365 
201 U6.1 R3 430 n/a n/a n/a n/a 
201 U6.2 R3 442 1.461 0.041 687.1 0.6086 
201 U6.3 R3 449 1.408 0.066 1482.4 0.5954 
201 U6.4 R3 465 1.664 0.054 357.8 0.5839 



















202 U0.1 Baseline 112 3.185 0.165 1306.7 0.7804 
202 U0.2 Baseline 120 2.629 0.102 1450.3 0.609 
202 U0.3 Baseline 132 2.183 0.085 1243.4 2.0846 
202 U0.4 Baseline 141 1.878 0.203 869.6 2.1672 
202 U0.5 Baseline 149 1.866 0.063 969.1 1.0015 
202 U1.1 843 159 1.840 0.076 2005.2 0.7676 
202 U1.2 843 168 1.700 0.061 1361.0 0.7928 
202 U1.3 843 179 1.827 0.105 1826.0 0.2377 
202 U1.4 843 187 1.513 0.071 1450.7 0.7931 
202 U1.5 843 203 1.335 0.054 1239.8 1.2535 
202 U2.1 R1 215 1.484 0.100 792.6 1.1379 
202 U2.2 R1 223 1.187 0.033 1612.6 1.7376 
202 U2.3 R1 230 1.052 0.054 1127.6 1.0001 
202 U2.4 R1 243 1.200 0.044 807.5 0.9178 
202 U2.5 R1 256 1.235 0.068 1036.6 1.1566 
202 U3.1 576 269 0.924 0.051 729.7 1.1581 
202 U3.2 576 277 1.003 0.031 1440.5 0.9293 
202 U3.3 576 291 1.054 0.042 1129.5 0.8565 
202 U3.4 576 297 0.984 0.030 1295.1 0.6641 
202 U3.5 576 310 1.052 0.068 1027.3 1.0796 
202 U4.1 R2 323 1.020 0.048 1089.5 1.3132 
202 U4.2 R2 332 0.987 0.039 1974.1 0.2215 
202 U4.3 R2 n/a n/a n/a n/a n/a 
202 U4.4 R2 354 0.937 0.039 1718.0 0.5503 
202 U4.5 R2 364 0.880 0.033 1623.0 0.4267 
202 U5.1 709 375 0.866 0.028 2504.9 0.3083 
202 U0.1 Baseline 112 3.185 0.165 1306.7 0.7804 
202 U0.2 Baseline 120 2.629 0.102 1450.3 0.609 
202 U0.3 Baseline 132 2.183 0.085 1243.4 2.0846 
202 U0.4 Baseline 141 1.878 0.203 869.6 2.1672 
202 U0.5 Baseline 149 1.866 0.063 969.1 1.0015 
202 U1.1 843 159 1.840 0.076 2005.2 0.7676 
202 U1.2 843 168 1.700 0.061 1361.0 0.7928 



















204 U0.1 Baseline 5267 8.053 0.175 1946.1 0.4798 
204 U0.2 Baseline 5277 9.779 0.296 1433.4 0.6263 
204 U0.3 Baseline 5287 10.755 0.568 1886.1 0.5172 
204 U0.4 Baseline 5297 9.355 0.227 1596.5 0.5607 
204 U0.5 Baseline 5306 9.845 0.365 1598.2 0.513 
204 U1.1 843 5317 9.643 0.372 2015.5 0.4991 
204 U1.2 843 5327 9.561 0.286 1650.4 0.5339 
204 U1.3 843 5336 9.673 0.354 1667.1 0.5639 
204 U1.4 843 5346 9.956 0.409 1754.3 0.5656 
204 U1.5 843 5357 9.822 0.372 2255.8 0.4358 
204 U2.1 R1 5368 10.369 0.245 1500.2 0.6019 
204 U2.2 R1 5378 9.642 0.159 1648.3 0.3774 
204 U2.3 R1 5388 9.620 0.188 1805.2 0.4205 
204 U2.4 R1 5398 9.274 0.183 1709.4 1.0524 
204 U2.5 R1 5407 9.333 0.236 1607.2 0.6353 
204 U3.1 709 5421 9.339 0.232 1581.6 0.621 
204 U3.2 709 5428 9.557 0.296 1813.2 0.4147 
204 U3.3 709 5437 9.997 0.212 1628.6 0.5609 
204 U3.4 709 5448 9.939 0.255 1867.7 0.4282 
204 U3.5 709 5457 10.044 0.245 2424.7 0.4481 
204 U4.1 R2 5468 10.396 0.346 1315.8 0.5815 
204 U4.2 R2 5478 9.939 0.231 1653.7 0.353 
204 U4.3 R2 5487 9.668 0.212 1959.9 0.3699 
204 U4.4 R2 5497 9.061 0.340 2108.0 0.4857 
204 U4.5 R2 5512 9.972 0.241 1655.5 0.5043 
204 U5.1 576 5521 10.152 0.284 1905.2 0.4581 
204 U5.2 576 5528 10.414 0.291 1729.0 0.5035 
204 U5.3 576 5540 10.459 0.216 2177.5 0.4696 
204 U5.4 576 5551 10.045 0.280 2273.5 0.4015 
204 U5.5 576 5560 9.253 0.269 2168.3 0.3807 
204 U6.1 R3 5572 9.492 0.199 2070.3 0.3367 
204 U6.2 R3 5581 9.218 0.177 2120.1 0.2987 
204 U6.3 R3 5590 8.709 0.274 2633.7 0.3631 
204 U6.4 R3 5600 9.570 0.372 2248.9 0.3168 



















205 U0.1 Baseline 117 3.072 0.127 1816.9 0.2497 
205 U0.2 Baseline 118 2.807 0.089 1686.8 0.4403 
205 U0.3 Baseline 128 2.452 0.086 1875.2 0.4519 
205 U0.4 Baseline 138 2.213 0.054 1652.5 0.1666 
205 U0.5 Baseline 147 2.095 0.051 2384.8 0.3105 
205 U1.1 576 159 2.071 0.084 2098.0 0.2857 
205 U1.2 576 166 1.814 0.064 2345.4 0.1551 
205 U1.3 576 179 1.734 0.037 2003.6 0.2405 
205 U1.4 576 188 1.776 0.064 2067.6 0.185 
205 U1.5 576 197 1.770 0.048 2119.3 0.1881 
205 U2.1 R1 207 1.699 0.076 1962.6 0.1655 
205 U2.2 R1 217 1.512 0.042 1928.0 0.4328 
205 U2.3 R1 229 1.503 0.058 1758.7 0.1666 
205 U2.4 R1 236 1.419 0.038 1392.9 0.2352 
205 U2.5 R1 248 1.395 0.041 2164.3 0.7107 
205 U3.1 709 260 1.257 0.049 2067.6 0.5131 
205 U3.2 709 269 1.275 0.054 2848.0 0.36 
205 U3.3 709 280 1.302 0.038 2678.9 0.2316 
205 U3.4 709 291 1.295 0.046 2254.2 0.5205 
205 U3.5 709 298 1.279 0.035 2158.9 0.5244 
205 U4.1 R2 310 1.173 0.048 1789.5 0.2394 
205 U4.2 R2 319 1.106 0.036 2409.5 0.1914 
205 U4.3 R2 327 1.106 0.061 2007.9 0.1 
205 U4.4 R2 338 1.043 0.057 2436.1 0.2026 
205 U4.5 R2 371 1.070 0.036 1790.5 0.4308 
205 U5.1 843 384 1.020 0.036 2154.1 0.2028 
205 U5.2 843 396 0.966 0.030 2526.3 0.1851 
205 U5.3 843 403 0.994 0.031 2007.3 0.2624 
205 U5.4 843 413 0.913 0.026 1672.0 0.3522 
205 U5.5 843 422 1.262 0.034 1755.3 0.1388 
205 U6.1 R3 433 0.950 0.044 2817.0 0.2565 
205 U6.2 R3 442 0.877 0.028 2667.7 0.222 
205 U6.3 R3 452 0.893 0.037 2331.4 0.3252 
205 U6.4 R3 463 0.917 0.034 2392.4 0.2155 



















206 U0.1 Baseline 109 6.035 0.225 1660.7 0.3132 
206 U0.2 Baseline 120 4.933 0.173 1621.6 0.4491 
206 U0.3 Baseline 130 3.917 0.156 1941.2 0.4915 
206 U0.4 Baseline 139 3.537 0.103 977.4 1 
206 U0.5 Baseline 148 3.854 0.113 1001.1 0.5444 
206 U1.1 843 160 3.468 0.144 1000.9 0.3884 
206 U1.2 843 170 3.154 0.093 1013.6 0.8476 
206 U1.3 843 182 3.142 0.108 998.1 0.622 
206 U1.4 843 189 3.249 0.177 872.2 0.4687 
206 U1.5 843 197 2.689 0.095 951.4 0.9602 
206 U2.1 R1 209 2.605 0.069 1002.6 1.6388 
206 U2.2 R1 218 2.635 0.086 998.4 0.7867 
206 U2.3 R1 229 2.320 0.067 947.6 0.8933 
206 U2.4 R1 237 2.276 0.069 1241.0 0.8849 
206 U2.5 R1 250 2.167 0.056 975.1 0.8578 
206 U3.1 576 260 2.128 0.064 941.9 0.2615 
206 U3.2 576 270 1.746 0.065 600.0 1.5182 
206 U3.3 576 281 1.914 0.049 976.7 0.5814 
206 U3.4 576 297 1.774 0.039 1390.2 0.421 
206 U3.5 576 301 1.795 0.072 1034.4 0.5774 
206 U4.1 R2 312 1.716 0.058 1000.8 0.3819 
206 U4.2 R2 321 1.628 0.046 1186.9 0.4838 
206 U4.3 R2 332 1.615 0.051 999.9 0.7112 
206 U4.4 R2 341 1.519 0.058 1250.5 0.5584 
206 U4.5 R2 355 1.443 0.069 689.5 0.8734 
206 U5.1 709 365 1.559 0.060 999.5 0.8412 
206 U5.2 709 376 1.490 0.058 1044.3 0.8778 
206 U5.3 709 384 1.427 0.055 977.7 0.7466 
206 U5.4 709 396 1.328 0.060 730.0 1.4762 
206 U5.5 709 406 1.309 0.028 1005.9 0.605 
206 U6.1 R3 412 1.442 0.034 931.8 0.616 
206 U6.2 R3 427 1.473 0.053 1190.6 1.0491 
206 U6.3 R3 436 1.286 0.049 1157.5 1.0418 
206 U6.4 R3 446 1.242 0.056 1455.2 1.2501 



















208 U0.1 Baseline 109 3.824 0.114 2596.4 0.3552 
208 U0.2 Baseline 119 3.778 0.101 2444.0 0.4962 
208 U0.3 Baseline 130 3.507 0.092 2063.6 0.1692 
208 U0.4 Baseline 139 2.850 0.093 1804.0 0.9736 
208 U0.5 Baseline 150 2.813 0.108 1911.9 0.538 
208 U1.1 709 162 low current low current 1772.5 0.1605 
208 U1.2 709 171 2.360 0.079 2165.4 0.3263 
208 U1.3 709 182 2.011 0.070 2089.3 0.3473 
208 U1.4 709 191 2.258 0.096 2426.6 0.1 
208 U1.5 709 199 2.478 0.115 1254.5 0.1807 
208 U2.1 R1 209 2.226 0.058 2440.2 0.5552 
208 U2.2 R1 220 2.072 0.057 2930.6 0.5023 
208 U2.3 R1 229 2.122 0.063 1690.4 0.7449 
208 U2.4 R1 239 2.172 0.096 2686.1 0.1938 
208 U2.5 R1 249 1.934 0.059 1776.9 0.798 
208 U3.1 576 263 1.854 0.124 1793.4 0.9359 
208 U3.2 576 269 1.795 0.078 1811.5 0.3546 
208 U3.3 576 278 1.713 0.054 1758.6 0.7377 
208 U3.4 576 289 1.882 0.055 2191.9 0.4176 
208 U3.5 576 298 1.907 0.059 1747.7 0.4465 
208 U4.1 R2 309 1.992 0.064 2441.4 0.3478 
208 U4.2 R2 320 1.894 0.087 1798.8 0.4722 
208 U4.3 R2 330 1.891 0.081 1667.3 0.4952 
208 U4.4 R2 339 1.852 0.079 1793.5 0.3861 
208 U4.5 R2 353 1.719 0.081 1916.2 0.4661 
208 U5.1 843 361 1.700 0.073 1661.7 0.5005 
208 U5.2 843 372 1.748 0.073 2358.7 0.4249 
208 U5.3 843 382 1.736 0.066 1905.0 0.3946 
208 U5.4 843 392 1.780 0.046 2146.9 0.4483 
208 U5.5 843 402 1.706 0.066 1914.8 0.3455 
208 U6.1 R3 413 1.688 0.040 2134.0 0.2066 
208 U6.2 R3 423 low current low current 1683.0 0.3155 
208 U6.3 R3 431 1.603 0.050 2133.1 0.4154 
208 U6.4 R3 441 1.599 0.042 2059.7 0.3632 



















209 U0.1 Baseline 127 2.454 0.126 901.0 1.2181 
209 U0.2 Baseline 136 2.234 0.094 944.9 0.8076 
209 U0.3 Baseline 148 2.169 0.062 745.9 0.6658 
209 U0.4 Baseline 156 1.640 0.077 814.8 2.7162 
209 U0.5 Baseline 166 2.218 0.070 647.5 0.3035 
209 U1.1 709 181 2.139 0.062 854.4 0.3848 
209 U1.2 709 191 2.039 0.077 862.7 0.637 
209 U1.3 709 202 2.168 0.048 544.0 0.2039 
209 U1.4 709 210 1.886 0.049 1003.4 0.3985 
209 U1.5 709 221 1.701 0.068 857.3 0.8844 
209 U2.1 R1 235 1.601 0.037 1266.8 0.705 
209 U2.2 R1 242 1.638 0.082 751.6 1.3194 
209 U2.3 R1 252 1.472 0.056 969.7 1.6456 
209 U2.4 R1 264 1.584 0.068 581.5 1.2091 
209 U2.5 R1 273 1.597 0.036 540.2 0.963 
209 U3.1 576 287 1.571 0.054 842.1 0.3365 
209 U3.2 576 296 1.423 0.080 899.2 0.907 
209 U3.3 576 306 1.545 0.059 495.1 0.7302 
209 U3.4 576 318 1.349 0.052 638.6 1.0896 
209 U3.5 576 328 1.423 0.049 1118.7 0.3295 
209 U4.1 R2 343 0.817 0.094 648.0 1.4602 
209 U4.2 R2 349 1.271 0.043 856.3 0.4248 
209 U4.3 R2 360 1.064 0.054 577.0 1.8086 
209 U4.4 R2 368 1.183 0.034 471.9 0.681 
209 U4.5 R2 378 1.098 0.063 691.4 1.1438 
209 U5.1 843 390 1.174 0.025 813.4 0.458 
209 U5.2 843 399 1.116 0.033 939.7 0.9373 
209 U5.3 843 410 1.123 0.030 722.6 1.3238 
209 U5.4 843 419 1.118 0.042 518.2 1.6781 
209 U5.5 843 430 0.952 0.040 687.0 0.3761 
209 U6.1 R3 440 1.152 0.056 787.7 1.0645 
209 U6.2 R3 451 1.077 0.055 736.6 0.9405 
209 U6.3 R3 462 1.129 0.111 703.0 1.7891 
209 U6.4 R3 471 0.918 0.028 816.8 1.5009 



















210 U0.1 Baseline 112 4.208 0.224 618.5 1.5997 
210 U0.2 Baseline 120 3.834 0.126 584.0 1.2173 
210 U0.3 Baseline 129 3.964 0.128 974.8 0.7234 
210 U0.4 Baseline 139 3.260 0.126 521.5 1.0821 
210 U0.5 Baseline 149 3.335 0.101 1186.2 0.5916 
210 U1.1 576 159 2.644 0.091 415.9 1.1883 
210 U1.2 576 170 3.169 0.106 652.2 1.0977 
210 U1.3 576 179 2.992 0.158 782.0 0.59 
210 U1.4 576 190 2.784 0.131 775.2 1.2872 
210 U1.5 576 201 2.548 0.080 840.8 0.7722 
210 U2.1 R1 210 2.114 0.061 740.5 1.3622 
210 U2.2 R1 221 2.236 0.107 819.4 0.9791 
210 U2.3 R1 230 1.958 0.049 7.8 1.0093 
210 U2.4 R1 242 2.064 0.085 505.3 1.0689 
210 U2.5 R1 250 1.889 0.094 620.4 2.0028 
210 U3.1 843 259 1.752 0.063 798.2 1.3818 
210 U3.2 843 270 1.927 0.060 649.0 1.3233 
210 U3.3 843 282 1.842 0.046 1210.5 0.5575 
210 U3.4 843 291 1.872 0.054 889.8 0.5057 
210 U3.5 843 300 1.702 0.082 538.9 1.583 
210 U4.1 R2 311 1.698 0.078 676.3 1.0416 
210 U4.2 R2 320 1.550 0.061 732.5 1.2039 
210 U4.3 R2 332 1.561 0.053 1162.2 0.4985 
210 U4.4 R2 342 1.611 0.119 596.3 0.9433 
210 U4.5 R2 360 1.575 0.062 735.8 1.4549 
210 U5.1 709 371 1.652 0.050 806.6 0.856 
210 U5.2 709 382 1.224 0.055 821.2 0.9849 
210 U5.3 709 391 1.440 0.038 1008.9 0.3946 
210 U5.4 709 402 1.341 0.040 716.5 1.1235 
210 U5.5 709 413 1.421 0.056 820.9 1.8697 
210 U6.1 R3 422 1.458 0.051 536.8 1.1758 
210 U6.2 R3 432 1.452 0.064 991.9 0.6382 
210 U6.3 R3 444 1.567 0.074 590.3 1.0864 
210 U6.4 R3 453 1.582 0.076 553.3 0.6386 



















211 U0.1 Baseline 100 2.837 0.123 1240.3 1.9044 
211 U0.2 Baseline 113 2.900 0.113 1857.3 0.5961 
211 U0.3 Baseline 120 2.658 0.110 893.2 1.1252 
211 U0.4 Baseline 132 2.443 0.100 1303.8 0.7567 
211 U0.5 Baseline 142 2.192 0.082 1036.4 1.8579 
211 U1.1 709 153 2.293 0.091 1369.4 1.1437 
211 U1.2 709 162 1.975 0.061 862.3 1.4494 
211 U1.3 709 173 2.170 0.106 1209.2 0.8178 
211 U1.4 709 183 2.013 0.064 981.0 1.0703 
211 U1.5 709 193 1.932 0.114 1180.8 0.8794 
211 U2.1 R1 204 1.734 0.046 866.1 1.438 
211 U2.2 R1 214 1.722 0.048 816.1 0.9064 
211 U2.3 R1 221 1.528 0.051 1115.5 0.7783 
211 U2.4 R1 235 1.553 0.051 1065.6 0.9378 
211 U2.5 R1 244 1.502 0.088 769.5 1.5987 
211 U3.1 843 256 1.595 0.051 1225.3 2.0109 
211 U3.2 843 266 1.627 0.053 1354.5 0.9323 
211 U3.3 843 277 1.775 0.064 1466.2 0.8025 
211 U3.4 843 283 1.557 0.065 670.7 1.4932 
211 U3.5 843 293 1.485 0.058 1076.9 1.4473 
211 U4.1 R2 303 1.492 0.053 1231.2 0.861 
211 U4.2 R2 313 1.493 0.062 958.4 0.9232 
211 U4.3 R2 324 1.311 0.060 1100.3 0.934 
211 U4.4 R2 335 1.472 0.076 1014.4 1.0748 
211 U4.5 R2 347 1.541 0.082 1062.9 1.1948 
211 U5.1 576 357 1.504 0.053 947.4 1.1524 
211 U5.2 576 367 1.533 0.054 1093.0 0.9771 
211 U5.3 576 377 1.354 0.068 1011.6 1.0036 
211 U5.4 576 388 1.332 0.054 978.3 1.3222 
211 U5.5 576 n/a n/a n/a n/a n/a 
211 U6.1 R3 409 1.346 0.046 888.6 2.2772 
211 U6.2 R3 419 1.322 0.046 1449.6 0.9159 
211 U6.3 R3 429 1.401 0.055 1072.3 0.9807 
211 U6.4 R3 443 1.443 0.047 1177.3 0.8909 



















213 U0.1 Baseline 110 5.302 0.140 1686.3 0.3392 
213 U0.2 Baseline 123 5.664 0.228 1806.2 0.1773 
213 U0.3 Baseline 131 5.143 0.167 1536.7 0.4487 
213 U0.4 Baseline 140 4.548 0.124 1962.9 0.3694 
213 U0.5 Baseline 150 4.262 0.117 1797.4 0.175 
213 U1.1 576 164 3.854 0.145 1243.7 0.937 
213 U1.2 576 173 3.800 0.085 1915.0 0.1775 
213 U1.3 576 184 3.403 0.114 1899.8 0.4181 
213 U1.4 576 193 3.165 0.100 1718.7 0.1 
213 U1.5 576 200 3.243 0.061 1892.7 0.2204 
213 U2.1 R1 212 3.657 0.207 1198.7 0.3789 
213 U2.2 R1 223 3.671 0.306 1473.7 0.3335 
213 U2.3 R1 230 3.435 0.084 1816.8 0.3979 
213 U2.4  R1 240 3.372 0.071 1671.6 0.406 
213 U2.5 R1 250 3.348 0.105 1241.9 0.4726 
213 U3.1 843 264 3.050 0.120 1058.5 0.4643 
213 U3.2 843 274 2.939 0.124 1164.9 0.1961 
213 U3.3 843 282 3.099 0.111 1348.4 0.3028 
213 U3.4 843 291 2.916 0.066 1184.4 0.6035 
213 U3.5 843 295 2.825 0.055 1415.5 0.2721 
213 U4.1 R2 316 2.841 0.098 1236.7 0.5207 
213 U4.2 R2 324 2.893 0.088 1461.4 0.3794 
213 U4.3 R2 335 2.679 0.070 1335.6 0.3189 
213 U4.4 R2 352 2.412 0.088 1493.2 0.3772 
213 U4.5 R2 358 2.212 0.105 1493.3 0.3328 
213 U5.1 709 369 2.139 0.074 1511.6 0.6373 
213 U5.2 709 380 2.063 0.056 1836.0 0.3341 
213 U5.3 709 388 2.359 0.061 1831.9 0.1718 
213 U5.4 709 399 2.248 0.108 1366.1 0.4886 
213 U5.5 709 410 2.010 0.049 1032.0 0.2103 
213 U6.1 R3 421 1.876 0.076 979.4 0.448 
213 U6.2 R3 431 1.971 0.052 1182.4 0.6332 
213 U6.3 R3 440 1.777 0.059 1541.9 0.4835 
213 U6.4 R3 454 1.749 0.056 1037.9 0.5776 



















214 U0.1 Baseline 106 6.068 0.172 1429.8 0.6571 
214 U0.2 Baseline 120 5.337 0.297 1114.1 0.4015 
214 U0.3 Baseline 129 4.733 0.107 1455.5 0.3297 
214 U0.4 Baseline 138 4.462 0.088 1454.9 0.2615 
214 U0.5 Baseline 148 4.117 0.123 1215.4 0.6878 
214 U0.6 Baseline 161 3.544 0.144 1403.1 0.2414 
214 U1.1 843 173 3.300 0.075 1717.4 0.1836 
214 U1.2 843 171 3.087 0.143 1314.9 0.4356 
214 U1.3 843 190 3.104 0.067 1343.7 0.2865 
214 U1.4 843 201 3.061 0.095 -304.2 0.3135 
214 U1.5 843 211 2.865 0.108 849.7 0.6185 
214 U2.1 R1 223 2.413 0.060 1539.9 0.2589 
214 U2.2 R1 231 2.524 0.063 1103.2 0.3648 
214 U2.3 R1 242 2.575 0.111 1417.4 0.2139 
214 U2.4 R1 256 2.115 0.059 1740.0 0.2457 
214 U2.5 R1 265 2.466 0.063 1128.6 0.2719 
214 U3.1 709 272 2.154 0.060 1287.4 1.3149 
214 U3.2 709 284 2.101 0.041 1828.8 0.2756 
214 U3.3 709 293 2.099 0.054 1489.1 0.8031 
214 U3.4 709 304 2.127 0.045 1298.9 0.4377 
214 U3.5 709 314 2.196 0.055 321.8 0.2916 
214 U4.1 R2 324 1.873 0.074 1193.0 0.4717 
214 U4.2 R2 334 1.872 0.053 1702.1 0.3951 
214 U4.3 R2 348 1.743 0.064 1189.1 0.5281 
214 U4.4 R2 356 1.927 0.077 1697.7 0.4029 
214 U4.5 R2 368 1.741 0.043 1464.2 0.3507 
214 U5.1 576 380 1.637 0.038 1342.2 0.1533 
214 U5.2 576 388 1.669 0.047 1757.0 0.2352 
214 U5.3 576 402 1.667 0.036 1121.6 0.5539 
214 U5.4 576 409 1.687 0.037 1298.0 0.445 
214 U5.5 576 419 2.464 0.061 1676.9 0.1307 
214 U6.1 R3 431 1.623 0.041 1758.5 0.2551 
214 U6.2 R3 440 1.603 0.065 1709.2 0.4533 
214 U6.3 R3 450 1.353 0.043 1401.4 0.482 



















218 U0.1 Baseline 2011 0.664 0.032 1169.5 0.7813 
218 U0.2 Baseline 2019 0.631 0.031 1354.7 0.4013 
218 U0.3 Baseline 2030 0.705 0.036 973.4 0.6235 
218 U0.4 Baseline 2040 0.726 0.042 1256.0 0.5031 
218 U0.5 Baseline 2051 0.856 0.393 1675.1 0.1782 
218 U1.1 576 2064 no data no data 1541.7 0.2697 
218 U1.2 576 2073 0.722 0.024 2574.0 0.1 
218 U1.3 576 2080 0.718 0.032 1576.1 0.9042 
218 U1.4 576 2093 0.718 0.060 1122.6 0.7184 
218 U1.5 576 2106 0.649 0.042 2173.6 0.1 
218 U2.1 R1 2116 0.737 0.037 1488.6 1.0897 
218 U2.2 R1 2127 0.662 0.045 1674.4 0.8594 
218 U2.3 R1 2136 0.729 0.031 1999.5 0.8222 
218 U2.4 R1 2147 0.708 0.039 1167.6 1.0162 
218 U2.5 R1 2155 0.867 0.123 2024.0 0.2024 
218 U3.1 709 2167 0.696 0.051 1823.5 0.4185 
218 U3.2 709 2177 0.714 0.031 1416.5 0.4681 
218 U3.3 709 2184 0.648 0.050 1680.8 0.334 
218 U3.4 709 2197 0.679 0.034 1447.6 0.3375 
218 U3.5 709 2207 0.804 0.062 1186.8 0.6348 
218 U4.1 R2 2215 low current low current 1222.7 0.3293 
218 U4.2 R2 2227 low current low current 1295.9 0.358 
218 U4.3 R2 2238 0.792 0.070 1013.9 0.74 
218 U4.4 R2 2247 0.751 0.024 1096.4 0.6103 
218 U4.5 R2 2259 0.820 0.022 1634.6 0.3221 
218 U5.1 843 2269 low current low current 1675.4 0.2611 
218 U5.2 843 2280 0.778 0.043 1241.1 0.6264 
218 U5.3 843 2289 0.723 0.036 1037.0 0.7744 
218 U5.4 843 2300 0.794 0.046 1424.6 0.4843 
218 U5.5 843 2310 0.804 0.051 1575.5 0.6918 
218 u6.1 R3 2320 0.776 0.082 826.7 1.1868 
218 u6.2 R3 2331 0.771 0.082 850.8 1.0106 
218 u6.3 R3 2342 0.894 0.056 1046.1 0.1659 
218 u6.4 R3 2351 0.772 0.056 1374.4 0.4644 
218 u6.5 R3 2362 0.792 0.070 1680.7 0.4002 
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Ca Kinetics Pool Size and Compartment Transfer Rates 
Control Rats 
Unit 301 301 303 303 
(/min) L(2,1) 0.076361 L(2,1) 0.076361 
(/min) L(1,2) 0.004851 L(1,2) 0.004851 
(/min) L(2,3) 0.002574 L(2,3) 0.002574 
(/min) L(3,2) 0.007893 L(3,2) 0.007893 
(/min) L(0,3) 0.001328 L(0,3) 0.001328 
(/min) L(6,1) 5.58E-05 L(6,1) 5.58E-05 
(/min) L(10,9) 0.002314 L(10,9) 0.00241 
(/min) L(1,10) 0.000636 L(1,10) 0.000481 
(/min) L(5,10) 0.005362 L(5,10) 0.005898 
(/min) L(12,11) 0.076361 L(12,11) 0.076361 
(/min) L(11,12) 0.004851 L(11,12) 0.004851 
(/min) L(12,13) 0.002574 L(12,13) 0.002574 
(/min) L(13,12) 0.007893 L(13,12) 0.007893 
(/min) L(0,13) 0.001328 L(0,13) 0.001328 
(/min) L(16,11) 5.58E-05 L(16,11) 5.58E-05 
(/min) L(20,19) 0.002314 L(20,19) 0.00241 
(/min) L(11,20) 0.000636 L(11,20) 0.000481 
(/min) L(15,20) 0.005362 L(15,20) 0.005898 
(mL) P(1) 15.9432 P(1) 15.9432 
(mL) P(11) 15.9432 P(11) 15.9432 
(fract. Of dose) P(20) 0.029523 P(20) 0.272897 
(fract. Of dose) P(16) 0.001059 P(16) 0.000206 
130 
 
LOW Dose Rats 
305 305 306 306 307 307 
L(2,1) 0.097809 L(2,1) 0.097809 L(2,1) 0.097809 
L(1,2) 0.003818 L(1,2) 0.003818 L(1,2) 0.003818 
L(2,3) 0.001588 L(2,3) 0.001588 L(2,3) 0.001588 
L(3,2) 0.00408 L(3,2) 0.00408 L(3,2) 0.00408 
L(0,3) 0.001208 L(0,3) 0.001208 L(0,3) 0.001208 
L(6,1) 0.000199 L(6,1) 0.000199 L(6,1) 0.000199 
L(10,9) 0.004305 L(10,9) 0.004688 L(10,9) 0.006076 
L(1,10) 0.000362 L(1,10) 0.000359 L(1,10) 0.000346 
L(5,10) 0.003136 L(5,10) 0.002858 L(5,10) 0.0025 
L(12,11) 0.097809 L(12,11) 0.097809 L(12,11) 0.097809 
L(11,12) 0.003818 L(11,12) 0.003818 L(11,12) 0.003818 
L(12,13) 0.001588 L(12,13) 0.001588 L(12,13) 0.001588 
L(13,12) 0.00408 L(13,12) 0.00408 L(13,12) 0.00408 
L(0,13) 0.001208 L(0,13) 0.001208 L(0,13) 0.001208 
L(16,11) 0.000199 L(16,11) 0.000199 L(16,11) 0.000199 
L(20,19) 0.004305 L(20,19) 0.004688 L(20,19) 0.006076 
L(11,20) 0.000362 L(11,20) 0.000359 L(11,20) 0.000346 
L(15,20) 0.003136 L(15,20) 0.002858 L(15,20) 0.0025 
P(1) 15.9432 P(1) 15.9432 P(1) 15.9432 
P(11) 15.9432 P(11) 15.9432 P(11) 15.9432 
P(20) 0.202137 P(20) 0.003498 P(20) 0.189972 
P(16) 0.000109 P(16) 0 P(16) 0 
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HIGH Dose Rats 
308 308 309 309 310 310 311 311 
L(2,1) 0.073019 L(2,1) 0.073019 L(2,1) 0.073019 L(2,1) 0.07301 
L(1,2) 0.004379 L(1,2) 0.004379 L(1,2) 0.004379 L(1,2) 0.00437 
L(2,3) 0.00226 L(2,3) 0.00226 L(2,3) 0.00226 L(2,3) 0.0022 
L(3,2) 0.007511 L(3,2) 0.007511 L(3,2) 0.007511 L(3,2) 0.00751 
L(0,3) 0.001215 L(0,3) 0.001215 L(0,3) 0.001215 L(0,3) 0.00121 
L(6,1) 4.59E-05 L(6,1) 4.59E-05 L(6,1) 4.59E-05 L(6,1) 4.6E-05 
L(10,9) 0.002085 L(10,9) 0.002153 L(10,9) 0.002278 L(10,9) 0.00231 
L(1,10) 0.000622 L(1,10) 0.000346 L(1,10) 0.001147 L(1,10) 0.00048 
L(5,10) 0.004743 L(5,10) 0.003357 L(5,10) 0.012805 L(5,10) 0.00572 
L(12,11) 0.073019 L(12,11) 0.073019 L(12,11) 0.073019 L(12,11) 0.07301 
L(11,12) 0.004379 L(11,12) 0.004379 L(11,12) 0.004379 L(11,12) 0.00437 
L(12,13) 0.00226 L(12,13) 0.00226 L(12,13) 0.00226 L(12,13) 0.00226 
L(13,12) 0.007511 L(13,12) 0.007511 L(13,12) 0.007511 L(13,12) 0.00751 
L(0,13) 0.001215 L(0,13) 0.001215 L(0,13) 0.001215 L(0,13) 0.00121 
L(16,11) 4.59E-05 L(16,11) 4.59E-05 L(16,11) 4.59E-05 L(16,11) 4.6E-05 
L(20,19) 0.002085 L(20,19) 0.002153 L(20,19) 0.002278 L(20,19) 0.00231 
L(11,20) 0.000622 L(11,20) 0.000346 L(11,20) 0.001147 L(11,20) 0.00048 
L(15,20) 0.004743 L(15,20) 0.003357 L(15,20) 0.012805 L(15,20) 0.00572 
P(1) 15.9432 P(1) 15.9432 P(1) 15.9432 P(1) 15.943 
P(11) 15.9432 P(11) 15.9432 P(11) 15.9432 P(11) 15.943 
P(20) 0.115949 P(20) 0.130263 P(20) 0 P(20) 0.07781 
P(16) 0.000516 P(16) 0.000269 P(16) 0.001277 P(16) 0.00046 
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Calcium absorption inhibitor Ammonium Oxalate immediately prior to 45Ca cecal 
dose at a molar ratio of 85% of the amount of Calcium Ascorbate infused. 
Figure D.1: SCFAs May Protect Against Absorption Inhibition 
Minutes after dose 





























Figure D.3: SCFA Dose Timing May Effect Calcium Absorption 
 
 








































































Minutes after Dose 
